Prospective Randomised study on Postoperative Analgesia for Caesarean Section with Intrathecal Buprenorphine by Sasikumar, P
PROSPECTIVE RANDOMISED STUDY ON POSTOPERATIVE 
ANALGESIA FOR CAESAREAN SECTION WITH INTRATHECAL 
BUPRENORPHINE 
Dissertation submitted to 
THE TAMILNADU DR. M.G.R.MEDICAL UNIVERSITY 
 
in partial fulfilment for the award of the degree of 
DOCTOR OF MEDICINE 




INSTITUTE OF ANAESTHESIOLOGY & CRITICAL CARE 
MADRAS MEDICAL COLLEGE 
CHENNAI- 600 003 
CERTIFICATE 
      This is to certify that the dissertation work on  PROSPECTIVE 
RANDOMISED STUDY ON POSTOPERATIVE ANALGESIA FOR 
CAESAREAN SECTION WITH INTRATHECAL BUPRENORPHINE  is the 
bonafide work done by Dr.P.Sasikumar, Rajiv Gandhi Govt. General Hospital 
Madras Medical College, Chennai-600003 under my supervision and guidance in 
partial fulfilment of the regulations laid down by The Tamil Nadu Dr.M.G.R. 
Medical University, for the M.D., Anaesthesiology Branch X course during the 
academic period of  May 2011   to   April 2013 
 
 
Dr.V.Kanagasabai MD.,   Dr.M.Vasanthi,   MD.,D.A.,DNB    
Dean                          Director                  
Rajiv Gandhi Govt.General Hospital  Institute of Anaesthesiology & Madras 
Medical College              Critical Care  
Chennai- 600003              Madras Medical College   










 I, Dr.P.SASIKUMAR solemnly declare that this dissertation titled 
PROSPECTIVE RANDOMISED STUDY ON POSTOPERATIVE 
ANALGESIA FOR CAESAREAN SECTION WITH INTRATHECAL 
BUPRENORPHINE is a bonafide record of work done by me in the Department 
of Anaesthesiology, Govt. Kasturba Gandhi hospital for Women & children, 
Chennai – 600005, under the guidance of Professor Dr. NELLAIKUMAR, M.D., 
D.A., Department of Anaesthesiology, Govt. Kasturba Gandhi hospital for Women 
& Children, Chennai-600005. 
 
 This dissertation is submitted to The Tamil Nadu Dr.M.G.R. Medical 
University, Chennai, in partial fulfilment of the University regulations for the award 
of degree of M.D., Branch X (Anaesthesiology) examination to be held in April 
2013.            
Place: Chennai      Dr.P.SASIKUMAR                             
Date :         
 
Signature of the Guide Dr.S . Nellaikumar, M.D., D.A., 
Professor & Head of the Department  
Dept. Of  Anaesthesiology  
Govt. Kasturba Gandhi Hospital for Women & children 
Chennai – 600005. 
ACKNOWLEDGEMENT 
 
 I am greatly indebted to Dr.V.Kanagasabai, M.D., Dean, Madras Medical 
College and Rajiv Gandhi Government General Hospital , Chennai-600003 for 
allowing me to use the facilities of the Hospital to conduct this Study. 
 I express my deep gratitude to Dr. Vasanthi M.D., D.A.,DNB, Director, 
Institute of Anaesthesiology & critical Care forall her guidance and support. 
 My sincere thanks to Professors Dr.T.Venkatachalam, M.D., D.A.,       
Dr.B. Kala, M.D.,D.A., Dr.Esther Sudarshini Rajkumar, M.D., D.A., 
Dr.D.Gandhimathi,M.D.,D.A.,  Dr.Samuel Prabakar M.D.,D.A., for their help 
and encouragement. 
 My sincere thanks to Dr.C.R.Kanyakumari,M.D.,D.A., former 
Director,Institute of Anaesthesiology &Critical Care for being the driving force 
behind this study. 
 I express my heartfelt gratitude to my Guide Dr.S.Nellai Kumar, M.D.,D.A., 
for his constant guidance and invaluable help in every step of this study. 
 I am extremely thankful to all Assistant Professors for teaching me the 
intricacies of conducting this study. 
 I also express my thanks to all my colleagues for their co-operation and 
support for this study. 
I will be failing in my duty if I do not express my heartfelt gratitude to Mr. Albert 
joseph, Statistician for his patient guidance and expert advice in the statistical 
analysis of the study data. 
My sincere thanks to all the staff nurses and theatre personnel for their help 
for this study. 
I wish to express my thanks to my family and friends for their moral support 
and encouragement. 
Last , but not the least , my sincere thanks to all the patients for their consent 







1. INTRODUCTION         
2. AIM OF STUDY          
3. METHODS OF PAIN MEASUREMENT       
4. METHODS OF POST-OPERATIVE PAIN RELIEF    
5. ANATOMY          
6. NEUROPHYSIOLOGY OF PAIN        
7. PHARMACOLOGY         
8. ASSESSMENT OF NEWBORN       
9. REVIEW OF LITERATURE        
10.MATERIALS AND METHODS       
11.OBSERVATION AND RESULTS       
12.DISCUSSION          
13.SUMMARY          















FOR ALL THE HAPPINESS MANKIND CAN GAIN IS  NOT IN PLEASURE IN REST 
FROM PAIN 
                                                                                                             - John Dryden 
 The International Association for the Study of Pain defines pain as an 
“unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or described in terms of such damage”. 
Surgical trauma and pain is a real problem to the patient during postoperative 
period. Yet after all the efforts taken to make the intra-operative period pain free 
and stress free, the patients are left to fend for herself in the post operative period. 
 Post operative pain unfortunately under treated that is usually written in 
single line as injection fortwin 1cc i.m bid. This is due to traditional fear of 
respiratory depression and addiction and also lack of knowledge of 
pharmacodynamics and kinetics of opioid analgesics. 
As the anaesthesiologist alleviate pain of the patient he scores as the ideal 
person to manage postoperative pain. 
 Apart from obvious humanitarian reasons, postoperative pain increases 
morbidity and mortality. 
ADVERSE EFFECTS OF PAIN 
Respiratory system 
  Pain causes decreased pulmonary compliance, inability to breath and cough, 
a reflex increase in the tone of abdominal musculature during expiration and 
decreased diaphragmatic function. So it decreases functional residual capacity and 
FEV1 leading to hypoxia , hypercarbia, retension of secretions, atelectasis and 
pneumonia    
Cardiovascular system  
Pain stimulates the sympathetic nervous system resulting in 
tachycardia,increase in cardiac index , myocardial o2 consumption. If associated 
with hypoxia will lead to infarction. Decreased ambulation lead to venous stasis , 
increased risk of deep vein thrombosis and pulmonary embolism. 
Gastro intestinal system 
 Pain causes nausea vomitting ,urinary retension and paralytic ileus  
Neuroendocrine system 
 Pain increases sympathetic tone, increased catecholamine and catabolic 
hormones secretion(ACTH,ADH,Glucagon CAMP,Renin and Angiotensin II results 
in a catabolic state and Negative nitrogen balance.  
Psychological 
Pain causes fear anxiety, insomnia and apprehension 
Importance of post operative system: 
Post operative pain is not merely a symptom but the diseases itself. Adequate pain 
relief benefits a patient in following ways.  
Reduction of metabolic and endocrine stress response. 
Reduction of pulmonary complications. 
Reduction of cardiovascular complication. 
 Reduced incidence of deep vein thrombosis. 
Speedy recovery of gastro intestinal function. 
Less urinary retention. 
Prevention of chronic pain 
Early mobilisation recovery and decreased hospital stay 
Various technique has been tried as post operative pain relief , but spinal 
anaesthesia is a simple safe ad easier than other techniques. Spinal anaesthesia 
provides rapid onset and profound neuroblockade resulting in reduced need of 
supplemental analgesics. Adjuvant agents used along with local anaesthetics in 
caesarean delivery improve the quality of intraoperative anaesthesia, prolong 
postoperative analgesia, and reduce the dose, and therefore the side effects, of local 
anaesthetics. 
OPIOID-LOCAL ANAESTHETIC MIXTURES  
 The goal of combining spinal opioids and local anaesthetics is to use lower 
doses of each agent, to maintain good and effective analgesia, to reduce the side 
effects and to to blunt the stress response. The opioid in the mixture act by 
inhibiting the release of substance P in the dorsal horn of the spinal cord ; local 
anaesthetics block the transmission of impulses at the level of the nerve axonal 
membrane.there is synergy of analgesic effect.  
Commonly used local anaesthetic drug is bupivacaine  
Opioids used are fenanyl,morphine,buprenorphine 
Our study is a comparison of bupivacaine alone or along with buprenorphine 




 AIM OF STUDY 
 To compare the effectiveness of intrathecal 0.5%Heavy bupivacaine and 
Buprenorphine 60µg with 0.5%Heavy bupivacaine for postoperative analgesia in 
elective caesarean section. 
  
METHODS OF PAIN MEASUREMENT 
   Pain is a personal, subjective experience that comprises sensory- discriminative, 
motivational- affective and cognitive – evaluative dimensions. Since pain is 
subjective, the patient’s self report provides the most valid measure of the 
experience 
The various measures of pain used are : 
 1. Visual Analogue scale 
2. McGill pain Questionnaire 
3. Descriptor differential scale 
4. Verbal and Numerical Rating Scales  
 
 Visual Analogue Scale 
 The most common form consists of a scale with 10 cm horizontal line with 
two end-points labelled ‘no pain’ and ‘worst pain ever’. The patient is required to 
place a mark on the 10 cm line at a point that corresponds to the level of pain 
intensity he currently feels. 
 
Advantages 
1. It has ratio scale properties. 
2. It is minimally intrusive. 
3. It is conceptually simple. 
 Disadvantages 
1. Bias of expectancy for change and reliance on memory. 






METHODS OF POST-OPERATIVE PAIN RELIEF 
1. Opiates 
a) intramuscular 
b) continuous/intermittent intravenous  
c) Patient controlled Analgesia(PCA) 
d) Intrathecal 
e) epidural 
f) Others – oral, sublingual, Transdermal,Rectal 
2. Non-narcotic: 
 Invasive: 
a) Regional Anaesthesia 
b) Local anaesthetic infiltration 
c) Cryoanalgesia 
d) Continuous interpleural infusion 
e) Non-invasive: 
a) Inhalational 
b) Transcutaneous Electrical Nerve Stimulation (TENS) 
c) Hypnosis  
d) Acupuncture 
e) Relaxational technique.  
ANATOMY 
The bony spinal canal extends from foramen magnum to sacral hiatus. It is 
formed by the vertebral border inferiorly, pedicles by laterally and by laminae and 
spines posteriorly. Through the intervertebral foramina segmental nerves and blood 
vessels passes. 
Contents: 
1. Spinal nerve roots 
2. CSF ,membranes and spinal cord 
3. Venous plexus and alveolar tissue of extradural spaces  
SPINAL CORD 
- An elongated cylindrical mass of nervous tissue. 
- Length 42-45cm, weight – 30gm 
- Occupies upper 2/3rd of vertebral canal  
- Extends from atlas to L1 or L2 vertebra 
- The anterior and posterior roots of the most caudal  nerves emerge from the 
conical terminus of the spinal cord. 
 - Conus medullaris form bundle of nerves reffered as cauda equina upto S2 level 
- Pia mater continues caudally from conus medullaris terminale  Spinal nerves 
emerge in pair from the cord –  8 cervical,  12 thoracic,  5 lumbar,  5 sacral and one 
pair of coccygeal nerve. Anterior and posterior nerve roots cross the extradural 
space and ii the intervertebral foramina unite to form trunk which immediately 
divide into anterior and posterior primary division and mixed nerve.Nerve roots 
have no dural sheath in the dura mater, so the anaesthetic drugs easily diffuse into 
them.  
CURVES OF THE SPINE 
Cervical curve – convexity anterior 
Dorsal curve - convexity posterior 
Lumbar curve - convexity anterior 
Sacrococcygeal –convexity posterior  
High point of spinal curve – L3 
Low point                            - T5  
Blood supply : 
 Blood supply to spinal cord is derived from a single anterior spinal artery and 
two posterior spinal arteries. 
The anterior spinal artery is formed from vertebral artery at base of the skull 
and course down along the anterior surface of the cord. It supplies the anterior two-
thirds of the cord, whereas posterior spinal arteries supply the posterior one-third. 
 The posterior spinal arteries arise from the posterior inferior cerebellar 
arteries and course down along the dorsal surface of the cord medial to the dorsal 
nerve roots. 
 
Anatomical changes of pregnancy 
 The enlarged epidural veins may displace CSF from the thoracolumbar 
region of the subarachnoid space. This displacement partly explains the lowered 
dose requirement for spinal anaesthesia in pregnant women. 
Sub arachnoid dose requirement are also affected by low specific gravity of 
CSF in pregnant patients. 
 
A pregnant women’s pelvis rotates on the long axis of the spinal column ; 
thus , the line joining the iliac crest assumes a more cephalad relationship to the 
vertebral column.  
There is less space between adjacent lumbar spinous process during 
pregnancy. And the apex of lumbar lordosis is shifted caudad during pregnancy and 
the typical thoracic kyphosis in women is reduced in pregnancy.  
 Sub-arachnoid space : 
Sub arachnoid space is located between the pia and arachnoid mater. It 
includes the following structures : (i) CSF, (ii) spinal nerves (iii) a trabecular 
network between the membranes, (iv) blood vessels that supply the cord (v) lateral 
extension of the pia mater – dentate ligaments –these ligaments give lateral support 





Spinal anaesthesia is a form of regional anaesthesia obtained by blocking the 
spinal nerves in the sub arachnoid space by injecting local anaesthetic solution in to 
CSF, which mainly act on the spinal nerve roots.  
HISTORY: 
1885 - J.C corning administered cocaine intrathecally for pain 
1891 - Heinrich Irenaeus Quincke demonstrated technique of lumbar puncture in 
diagnosis 
1898 – august Bier of Germany produced true spinal anaesthesia in man 
1900 – Rudalph matas pioneer in spinal opioids 
1905 – Pitkin popularized the method of introducing agents intrathecally.  
1908 – Baker described the use of dextrose to increase, alcohol to decrease  the 
density of local anaesthetic solution 
Sites of action in order of importance are   
1. Primarily on the spinal cord nerve roots. 
2. Secondarily act on dorsal root ganglia and postero anterior horn synapse.  
Susceptibility of nerve fibre depends on 
1. Fibre size 
2. Degree of myelinisation and distance between the nodes of ranvier. 
3. Frequency of nerve impulse transmission   
Order of nerve block 
1. Autonomic preganglionic b fibres 
2. Temperature – cold then warmth is lost. 
3. Temperature discrimination is lost 
4. Slow pain followed by fast pain 
5. Tactile sense 
6. Motor blockade – extensors then flexors 
7. Pressure sense lost 




NEURAXIAL ANAESTHESIA: ANAESTHETIC IMPLICATIONS  
Technical consideration : 
Enhancement of lumbar lordosis results in reduced vertebral interspinous gap 
, creating technical difficulty 
Widening of the pelvis results in a head-down tilt when pregnant  
women in lateral position- may increase rostral spread of local anaesthetic solution.  
Anaesthetic dose requirements : 
Pregnant women exhibit a more rapid onset and a longer duration of spinal 
anaesthesia than nonpregnant due to enhanced neural sensitivity to local 
anaesthetics. Elevation in CSF pH may also contribute to this effects. 
 The dose of hyperbaric local anaesthetic required in term pregnant is 25% 
lower than in nonpregnant is due to  
i)  reduction of the spinal CSF volume, which accompanies distention of 
vertebral venous plexus; 
ii) enhanced neural susceptibility to local anaesthetics; 
iii) increased rostral spread, caused by the widening of the pelvis; 
iv)  inward displacement of intervertebral foraminal tissue, resulting from 
increased abdominal pressure; 
v) a higher level of the apex of the thoracic kyphosis during late pregnancy.  
NEUROPHYSIOLOGY OF PAIN 
Mechanism of pain 
 To deal intelligently with problems of pain , it requires great deal of 
familiarity with anatomy of sensory pathways sensory supply of body segments and 
insight into the psychological factors that influence behaviour and knowledge of 
medical and psychiatric diseases. 
 PAIN THEORIES 
 During nineteenth century many studies were undertaken that prompted the 
explicit formulation of two physiologic theories of pain the specificity theory and 
the intensive theory. The specificity theory of Von Frey stated that pain was a 
specific sensation with its own sensory apparatus, independent of touch and other 
senses. 
 The intensive (summation) theory of Goldscheider in 1894 states that 
stimulus intensity and central summation were the critical determinants of pain. 
 Later, pattern theories by Nafe in 1934 suggested that all cutaneous qualities 
are produced by spatial and temporal patterns of nerve impulses. 
Later in 1943, Livingston proposed his central summation theory.  
FOURTH THEORY OF PAIN 
 Hardy,Wolff and Goodell in 1940 introduced the concept of duality of pain. 
Pain can be separated into two components- perception of pain and reaction of pain. 
This concept assumes a one to one relationship between the intensity of stimulus 
and pain perception and relegates the reaction to pain as secondary response. 
SENSORY INTERACTION THEORY 
 Noordenbos in 1959 stated that large fibers inhibit and small fibers excite 
central transmission neurons, which project to a multi synaptic system that leads to 
the brain.  
GATE CONTROL THEORY  
 In 1965 Melzack and Wall propounded their gate control theory taking into 
account, the evidence of physiologic specialisation , central summation, patterning, 
modulation of input and the influence of psychological factors. 
  They observed in decerebrate and spinal cats that peripheral stimulation of 
large myelinated fibers produced a negative dorsal root potential and stimulation of 
small c fibers caused a positive dorsal root potential.  
 They postulated that these potentials which were a reflection of presynaptic 
inhibition or excitation modulated the activity of secondary transmitting neurons 
(Tcells) in the dorsal horn and that this modulation was mediated through an 
inhibitory neurons (I cells) in the substantia gelatinosa of Rolando. 
  Later refinement of the gate control hypothesis, Wall placed the T cells in 
lamina V of the dorsal Horn and still unidentified inhibition cells in the Lamina II 
and III. The essence of this theory is that large diameter fibers excite the I cells 
which then cause a presynaptic inhibition of the T cells. The small pain afferents 
inhibit the I cells leaving the T cells in an excitatory state. The gate comes under 
central control through the dorsal column and whos cell bodies lie in the medullary 
raphe nuclei, which may also inhibit pain transmission, presumably by action on the 
internuncial neuron.  
 Pathways of pain 
 Pain receptors in the skin and other tissues consists of un-myelinated free 
nerve endings, activated by high intensity stimuli which may be thermal, 
mechanical, electrical or chemical.  
 A delta fibers are finely myelinated and rapidly conducting 12-30m/sec. They 
conduct the sharp pain produced by pin prick, electrical or thermal stimuli and are 
responsible for withdrawal reflexes. A delta conducted pain is felt quickly and is 
well localized. 
  
C fibers are very fine non myelinated which conduct at a slow rate of 2-3 m/sec or 
less. Their threshold for stimulation is higher than that of A delta fibers and they are 
responsible for more delayed and truly noxious burning or throbbing pain. 
  Peripheral sensory nerves have their cell bodies in the dorsal root ganglion 
and the actual projections of Aδ and c fiber neurons enter the dorsal horn in the 
lateral division for the dorsal root. 
  In the Gray matter of the spinal cord cell bodies are arranged in a series of 
laminae which are given ROMAN NUMERALS with I at tipoff the dorsal horn. 
  Aδ and c primary afferent fibres terminated principally in the marginal layer 
Lamina I and Substantia gelatinosa II. Some of the neurons of the Lamina I which 
synapse with the Aδ fibres give off axons which ascend in the contralateral anterior 
column without synapsing with neurons in deeper layers. Majority of pain fibres 
however synapse in the substantia gelatinosa with intermediate neurons which send 
projections to deeper layers or with dendrites of neurons whose cell bodies reside in 
deeper layers principally lamina.  
 Central projection from cell bodies in lamina IV,V,VI with contribution from 
Lamina I cross midline in the anterior commissure to form the ventral 
spinothalamic tract which ends in the thalamus, principally in the ventro posterior 
nucleus, sending few fibers, enroute to the periaqueductal grey matter. The 
ventroposterior nucleusof the thalamus projects to the post central gyrus(sensory 
cortex) where anatomical representation is reasonably precise 
  Pain stimuli can also pass via interneuron to cell bodies in the intermediate 
grey matter (lamina VII & VII) who’s central projection also ascend in the 
contralateral anterolateral column forming spino reticular pathway. They pass via 
reticular formation to be relayed non-specifically over a wide and poorly localized 
area of cerebral cortex.  
Endogenous pain control mechanism: 
  An endogenous analgesia system was first demonstrated by Reynolds (1969) 
found that stimulation of the ventrolateral periaqueductal grey matter, in the rat, 
produced a profound analgesia without altering behaviour or motor activity. 
Diencephalons and rostral bulbar nuclei (Raaphe magnus and paragigantocellularis) 
have similar effect. 
 
 Physiology of pain 
 Pain has been transmitted through four distinct processes 1.Transduction: noxious 
stimuli converted into electrical signal by peripheral afferents. 
 2.Transmission : electrical signal is propagated along nociceptive pathways. 
 3.Modulation : Nociceptive signal is altered within the dorsal horn.  
4. Perception : Integration of nociceptive input with emotional and cognitive  
factors to create subjective pain. 
OPIOID RECEPTORS  
 From time immemorial opiates have been the best analgesics that man has 
ever known. The advancement in basic sciences has helped us to unravel the inbuilt 
endogenous opiate system. The narcotic analgesics drugs mitigate the 
responsiveness of human and animals to painful stimuli without affecting the other 
sensory modalities.  
 ENDOGENOUS OPIATE SYSTEM 
 It originates in the brain stem and modulates pain by exerting a descending 
influence at the first synapse for pain transmission in the spinal cord dorsal horn 
and the trigeminal nucleus caudalis through the opioid peptides. 
 Two different opioid peptide systems present in the CNS. The first is the 
small peptides methionine-encephalin and leucine-encephalin ,spread unevenly 
throughout the brain,spinal cord and peripheral nervous system. The second is the 
larger β-endorphin ,extending from the hypothalamic pituitary axis into the midline 
regions of the diencephalon and anterior pons.  
 Distribution 
 The opioid peptides exist in all vertebrates and many invertebrate species. 
The highest concentration is seen in pituitary gland. It is also seen in medial basal 
and arcuate region of the hypothalamus. 
  The large peptide β-endorphin is found in the small intestine , placenta and 
plasma, but its exact role in spinal cord is doubtful. 
 Enkephalin is distributed in amygdala, globus pallidus, striatum, 
hypothalamus, brainstem spinalcord dorsal laminae I, II,V of CNS. They are also 
present in the peripheral nervous system (peripheral ganglia, autonomic nervous 
system) adrenal medulla, GIT and plasma. Dynorphin, though found in the 
hypothalamo neurohypophyseal axis, its importance is unclear. 
  β-endorphin acts on epsilon receptor and has no role in analgesia but 
modulates nociception during stress. 
  Enkephalins acts as inhibitory neurotransmitters and elicit analgesia through 
the release of substance P in the dorsal horn. They also mediate acupuncture 
analgesia. Dynorphin has a nociception control at spinal level, through kappa 
receptor activation, than in the brain. The other roles for endogenous opioids are µ 
mediated antidiuresis and ĸ activated free water diuresis. 
 EXOGENOUS OPIOIDS AND OPIOID RECEPTORS 
 In 1976,Martin and coworkers proposed three classes of opiates based on the 
studies on chronic spinal dogs and named them according to prototype drugs. 
µ - Morphine 
ĸ – Ketocyclazocine 
σ – (SKF10,047) 
  Kosteshitz classification added delta receptor with affinity for leu 
enkephalins and a fifth receptor the epsilon receptor with a high affinity for β 
endorphin. 
Significant achievements 
1971          Demonstration of existence of opioid receptors by  
radioligand by Goldstein A et al. 
1973          Demonstration of opioid receptors in brain by Pert C.B. and Snyder 
S.H. 
1976          Demonstration of opioid receptors in spinal cord byLamotte .C.   Pert 
C.B. et al. 
1976         Demonstration of analgesia in animals by spinal opioids by 
Laksh T.L. and Rudy T.A. 
1979         Intrathecal opiates first used in man by Wang et al. 
 Mu receptors: 
  µ receptors are major antinociceptor site located in the brain and spinal cord 
with high concentration in the periaqueductal grey matter and substantia gelatinosa . 
Morphine is a typical agonist, and it mediate supraspinal analgesia, respiratory 
depression, euphoria and physical dependence.  
Mu1- high affinity- mediate analgesia  
Mu2- low affinity –no analgesia ;respiratory depression. 
Kappa receptors: 
  Ketocyclazocine and ethyl ketocyclazocine – agonists.Have greater effect on 
spinal nociceptive responses than supraspinal. Associated with sedation and miosis 
Sigma receptor: 
 Associated with pshycomimetic action of many opioid derivatives.  
Associated with mydriasis, tachycardia and mania. Typical agonist is N allyl  
norcyclazocine. 
Delta receptor: 
  Stable encephalin analogue D Aladien Enkephalin(DADL) has greater 
activity than Mu agonist. 
Epsilon receptor: 
Beta endorphins block electrical stimulation at this receptor, a stable peptide with 
opioid activity, present mainly in the pituitary 
CHARACTERISTICS OF OPIOID RECEPTORS 
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PHARMACOLOGY OF BUPRENORPHINE 
Buprenorphine is a semi synthetic highly lipophilic opioid derived from 
thebaine, an opium alkaloid related to morphine , and is a long acting analgesic with 
narcotic agonist and antagonist action. It is a white powder, weakly acidic and with 
limited solubility in water. 
 Structural formula 
 
 Buprenorphine HCl chemically is 17(cycloprophylmethyl) α (1,1 dimethyl 
ethyl) -4-5 epoxy -18-19 dihydro-3 hydroxy 6 methoxy αmethyl- 6, 14 –ethano –
morphinan  -7-methanol,hydrochloride(5,7(s)). It has a molecular formula  
C29H41NO4 HCl.  




Mechanism of Action 
Buprenorphine appears to have a high affinity for both µ and ĸ receptors low to 
moderate intrinsic activity at µ and ĸ receptors, in contrast the drug appears to have 
low to high affinity for and low intrinsic activity at δ receptors. Buprenorphine 
binds slowly with and dissociates slowly from the µ receptors.(this may account for 
the prolonged duration of analgesia )  
Clinical pharmacology 
Buprenorphine is an opiate analgesic 33 times more potent than morphine . 
Onset of action is slow and peak effect does not occur until 3hours. Duration of 
action <10hours. 
 Buprenorphine is metabolised in the liver and clearance is related to hepatic 
blood flow. 
Effect on the CNS:  
 Buprenorphine produces analgesia, sedation miosis and a lesser degree of 
nausea and vomiting which is exacerbated by movements. It may produce side 
effects like dizziness , sweating and headache 
 
Hemodynamic Effects of Agonist-Antagonist Compounds Compared with 
Morphine 







Morphine ↓ ↓ =↓ =↓ 
Buprenorphine ↓ ↓ ↓ ? 
Butorphanol ↑ =↑ = ↑ 
Nalbuphine ↓ = =↓ = 
Pentazocine ↑ ↑ ↑ ↑ 
 
 RESPIRATORY SYSTEM: 
  Buprenorphine depresses the respiratory centre and decreases both tidal 
volume and rate of respiration. It decreases minute ventilation at doses higher than 
3µg/kg, maximal respiratory depression observed 3hours later. Respiratory 
depression can be prevented by prior administraton of naloxone,but they are not 




 Buprenorphine is relatively well absorbed by most routes;including 
sublingual route 0.2 to 0.8mg produce satisfactory analgesia. 
High lipophilic substance and well absorbed across biological 
membranes.High hepatic clearance, sublingual administration enters directly  
Protein binding: 
Highly protein bound primarily to α and β globulin fraction(96%). Volume of 
distribution is 2.8L/Kg. 
METABOLISM: 
  Buprenorphine is metabolised in liver by N-dealkylation and glucuronide 
conjugation and the metabolites are – Buprenorphine 3 glucuronide and 
Norbuprenorphine and have lower affinity for µ receptors. 
 Metabolites are excreted through bile in the faeces, smaller amount appears 
in the urine. 
 Clearance rate : 20ml/Kg/min.  
 
 
 Preparation,Route of administration and Doses : 
  It is available as Buprenorphine hydrochloride. It is a clear, sterile solution 
for IV and IM administration and each ml contains 0.324mg hydrochloride ( 
equivalent to 0.3mg Buprenorphine) 50mg anhydrous dextrose, water and HCl to 
adjust pH.  
Preservative free Buprenorphine available as 0.3mg/ml also available. Also 
available as sublingual tablets 0.2 to 0.4mg.  
  
Therapeutic uses :  
1. As a premedicant  
2. As an analgesic in balanced N2O/O2 relaxant technique.  
3. In post-operative analgesia 
4. In acute pain of moderate to severe degree and chronic pain  
5. Sublingual Buprenorphine in preventing recurrence of pain following MI  
6. As in Neuraxial blockade for intra and post-operative pain relief. 
Precautions: 
1. To be used with caution in patients with compromised respiratory function (eg. 
COPD, corpulmonale, hypoxia , hypercapnia) or patients given other respiratory 
depressant drugs. 
2. To be used with caution in head injury, intracranial lesion and in circumstances 
where CSF pressure may be increased. 
3. Patients receiving other narcotics, phenothiazines, other tranquilizers, sedatives, 
hypnotics or other CNS depressants with Buprenorphine may exhibit an 
additive CNS depression.  
4. Should be cautiously used in elderly patients/ debilitated and those with severe 
hepatic , renal and pulmonary impairment.  
5. In myxoedema or hypothyroidism, adrenocortical suppression,CNS depression, 
coma, toxic psychosis, acute alcoholism and delirium tremens it may be used 
with caution. 
Tolerance and physical dependence: 
  Extensive investigations in a variety of animal species and models have 
identified a very low physical dependence liability. This has been confirmed in 
human volunteer studies (Jasinski D.B Pevink and Griffiths 1978) following 
naloxone challenge and abrupt withdrawl after high dose chronic administration by 
a subcutaneous route. It is considered to be a low addictive potential . 
Drug interactions:  
Care should be taken when Buprenorphine is used in combination with CNS 
depressant drugs and MAO inhibitors.  
Pregnancy : 
 No major fetal malformation was noted when administrated by IM or IV 
routes. 
  
PHARMACOLOGY OF BUPIVACAINE 
Bupivacaine is an aminoacyl amide synthetic local anaesthetic, which has 
been synthesised at AB Bofors by AF EKENSTAM et al.,(1957). Clinically used 
by Telivuoin in 1963. It is produced for clinical use as a racemic mixture of the 
enantiomers containing equal proportions of the ‘S’ and ‘R’ forms. 
Physicochemical Properties 
Bupivacaine has long been a butyl group on the piperidine nitrogen atom of 
the molecule. It is a long acting local anaesthetic drug with high anaesthetic 
potency. It is more lipid soluble, highly protein bound and has greater intrinsic 
potency.It is 3-4 times as potent as lignocaine. It crosses the placenta and the blood-
brain barrier.  
1. Molecular weight base - 288  
2. pKa- 8.1 
3. Partition coefficient- 346 
4. Mean uptake ratio- 3.3 
5. Protein Binding- 96% 
6. F/M ratio- 0.2 to 0.4  
 Pharmacological Properties 
Onset - moderate 
Relative potency - 8 
Duration - Long 
 Mechanism of action: 
 Bupivacaine produces its effects by dual action on sodium conductance. 1. 
Acts directly on the receptors within the sodium channels.  
2. Produces nonspecific membrane expansion  
Pharmacological effects 
a) Local : nerve blockade 
b) Regional : Pain, temperature, touch, motor power and  
 vasomotor tone in the region supplied by the  nerves are blocked. 
C) Systemic : Effects occurring as a result of systemic absorption or intravenous 
administration. 
  On the cardiovascular system, the effect of bupivacaine is dose related. It 
depresses the automaticity of the heart and myocardial contractility. Depending on 
the membrane potential and the rate of stimulation, bupivacaine depresses Vmax 
considerably more than lignocaine and results in slowed conductance of the cardiac 
action potential which is manifest by prolongation of PR interval and QRS duration 
on the electrocardiogram. This results in re-entrant phenomena and ventricular 
arrhythmias. The sodium channels are blocked in a “fast-in, slow out” manner 
which causes difficulty in resuscitation when ventricular fibrillation has occurred. 
The cardiotoxicity of bupivacaine results from high lipid solubility and the R-
enantiomer is more toxic than S-enantiomer. Bupivacaine produced more severe 
arrhythmias and the development of ECG disturbances and severe myocardial 
depression was more rapid . 
Pharmacokinetics: 
 Volume of distribution at steady state(Vdss) - 73 litres 
Terminal elimination half life - 210 minutes 
Clearance - 0.58 litres/min 
Plasma protein binding  - 96% 
Metabolism  - in Liver bydealkylation to pipecolyloxlidide  
Excretion - kidney – 5% as unchanged drug and rest as metabolites  
PREPARATION AVAILABLE 0.125% , 0.25% , 0.5% 
Maximal dose is 2mg/kg. 
 Pregnancy may affect the metabolism of bupivacaine. Pregnant women may 
have higher concentration of PPX concentration, but the unconjugated 4-hydroxy 
metabolite is not produced in significant amounts due to the effectsof hormonal 
changes on hepatic enzyme systems. Both Progesterone and estradiol are 
competitive inhibitors of microsomal oxidases, whereas reductive enzymes are 
induced by Progesterone. 
 Bupivacaine is bound extensively to AAG and albumin. This protein binding 
is reduced during late pregnancy in humans. 
ASSESSMENT OF THE NEWBORN 
Apgar score 
 In 1953, Dr. Virginia Apgar, an anaesthesiologist, described a simple 
method for the assessment of the newborn that could be performed while care was 
being delivered. She developed this system to provide a standardized and relatively 
objective method of assessing the newborn’s clinical status. 
 The Apgar score is based on five parameters that are assessed at 1minute 
and 5minutes after birth. Further scoring at 5- or 10-minutes intervals may be done 
if initial scores are low. 
 
Score of 8 to 10       =    normal 
Score of 4 to 7         =    moderate impairment 
Score of 0 to 3         =     need for immediate resuscitation 
The 5 minute of apgar score was a better predictor of neonatal death than the 
umbilical arterial blood pH. 
  Apgar scores can be low for a variety of reasons. Preterm delivery, 
congenital anomalies, neuromuscular diseases, antenatal drug exposure , 
manipulation at delivery and subjectivity and error may influence the Apgar score. 
 
 
Parameters  Score 
 0  1  2 
Heart rate Absent <100 >100 
Respiratory 
effort 
Absent Irregular, slow , 
shallow or gasping 
Robust, crying 






No response Grimace Active 
coughing and 
sneezing 








REVIEW OF LITERATURE 
  
REVIEW OF LITERATURE 
  Extracted from the POPPY, the opium alkaloid was named morphine after 
the Greek goddess of sleep, Morphina (also the Greek god of dreams, Morphews) in 
1803 by Fredrich Meisuer. 
1.  Synder (1973) discovered the opiate receptors in the dorsal horn of 
spinal cord, the lower medulla and the floor of the fourth ventricle and initiated the 
idea that subarachnoid injection of opiates could provide good analgesia 
2.  Huges et al (1975), the discovery of enkephalins and complex 
endogenous opiod systems initiated the opiod receptor theory and study of pain 
mechanisms. 
3.  Yakash and Rudy studied the spinal action of morphine in animals, the 
pain relief was attributed to the spinal analgesia caused by direct action of narcotics 
on specific opiate receptors. 
4.  Kay B (1978), studied the double blind comparison of the effects of 
morphine 10 mg IV and buprenorphine 0.3 mg IV in the prevention of pain after 
operation. The drugs were given by the anaesthetist at the end of surgery and the 
onset and severity of pain were assessed by a trained nurse. He found that with 
buprenorphine the pain relief was far more than twice that of morphine. The only 
side effect noticed was drowsiness. The incidence being greater after buprenorphine 
that after morphine 
5.  Wang et al (1979) reported the first use of intrathecal opiates in man. 
They studied 8 patients with intractable pain due to cancer of genito urinary tract 
with invasion of lumbosacral plexus. They injected 1 mg and 0.5 mg of morphine 
intrathecally and reported that the duration of pain relief ranged from 12-24 hours. 
6.  Cousins MJ and Glynn GJ (1979) reported the evidence of selective 
action of spinal narcotics. They found that 2 mg of Intrathecal morphine gave a pain 
relief of 24 hours after surgery. The absence of changes in sensory motor and 
sympathetic function indicates that this form of analgesia may have considerable 
advantage over other methods for the relief of severe chronic and acute pain in man. 
7.  Budd K. (1981) studied (IV) buprenorphine to produce analgesia in 
the immediate post operative period, the dose being titrated against the response of 
each patient in order to obtain complete freedom from pain. In 50 patients following 
LSCS under general anaesthesia, buprenorphine in the dose range 0.4 – 7.0 mg was 
found to be a potent, long lasting and safe analgesic. Serial blood gas estimations 
performed on ten of the patients confirmed the clinically observed lack of 
respiratory depression. 
8.  Watson and co-workers (1982), who found a longer duration of 
analgesia with buprenorphine 0.6 mg that 0.3 mg given IV after surgery. Analgesia 
and hormonal effects were greater with the greater dose without a parallel increase 
in respiratory depression. 
9.  Egan Lanz et al (1984), in their double blind study of post – operative 
analgesia, 158 patients who were given epidural analgesia with mepivacaine or 
bupivacaine with buprenorphine for orthopaedic surgery of lower extremities found 
that analgesia after 0.15 mg of Buprenorphine was superior to that after no 
injections for 6 hours after surgery. 0.3 mg of buprenorphine was superior both to 
no injections and to 0.15 mg of buprenorphine until 12th hour without any evidence 
of late respiratory depression. They concluded that epidural administration of 0.3 
mg of Buprenorphine may be recommended for post operative analgesia following 
orthopaedic surgery of lower extremities. 
10 . Green DW et al (1985), in a randomized double blind trail comparing 
morphine and buprenorphine and post operative analgesia combined with 
droperidol was conducted in 60 patients. Compared with morphine, taken as the 
standard analgesic, buprenorphine was shown to be a satisfactory analgesic for 
major surgery with no difference in incidence of unwanted effects. 
11.  Wolff J et al (1986), in a double blind controlled study, epidural 
buprenorphine 0.3 mg was compared with 4 mg of epidural morphine for post 
operative pain relief in the first 24 hours after major orthopaedic surgery. Duration 
of action was 620 minutes with buprenorphine with no side effects and 580 minutes 
with morphine with pruritis and urinary retention. 
12.  Lipp M et at (1987) in a double blind, randomized study of 29 patients 
who underwent orthopaedic procedures with the additional effect of intrathecal 
buprenorphine on isobaric spinal anaesthesia and post operative analgesia. The 
injections were 20 mg tetracaine (19 patients) or 20 mg tetracaine plus 0.15 mg 
buprenorphine (10) patients. After buprenorphine patients became aware of pain 
sensation 13 hours after injection; in the control group pain free intervals lasts only 
9 hours. There was no alteration in blood pressure and pulse rate was slightly 
diminished with buprenorphine group. 
13 . Capogna et al (1988), studied intrathecal 0.03 mg buprenorphine with 
bupivacaine 30 mg for post operative analgesia in the elderly patient showed 
prolonged analgesia with minimal disturbance of consciousness and comfortable 
breathing. The only side effects were nausea and vomiting in 11 and 14 patients 
respectively. 
14.  Calleno D et al (1989) spinal buprenorphine for post operative 
analgesia after ceasarian section. Group A (controls n = 15) received hyperbaric 
bupivacaine; group B and C received the same but with the addition of 0.03 mg or 
0.045 mg buprenorphine, respectively. Patient receiving higher dose had longer 
effect of 420 minutes than lower dose of 173 minutes analgesia without any 
increase in side effects. 
15.  Sen M (1992) studied intrathecal buprenorphine for post operative 
analgesia in orthopaedic surgery. Intrathecally either hyperbaric bupivacaine 1 ml in 
group A (30 cases) or bupivacaine 1 ml and buprenorphine 300 micrograms in 
combination was given, only minimal disturbance of consciousness and respiration 
were observed. The only side effect of buprenorphine group was nausea and 
vomiting in 10 patients. 
16.  Nishimi et al (1994) studied the effect of intrathecal administration of 
opioid on minimum alveolar concentration and postoperative pain relief a 
comparison of morphine and buprenorphine showed:· Intrathecal administration of 
0.05 mg and 0.075 mg of buprenorphine has shown analgesic effect without any 
side effects. With morphine 0.5 mg there was adequate post – operative analgesia 
with severe pruritus 
17.  Lundborg et al (1999), studied Intrathecal pain management for 
progressive systemic sclerosis with long term continuous intrathecal buprenorphine 
/ bupivacaine concluded intrathecal infusion of buprenorphine / bupivacaine 
provided satisfactory long term pain relief in a patient with PSS associated raynauds 
phenomenon, skin ulceration and intractable ischaemic pain. 
18.Sunil dixit et al., studied to compare intrathecal bupivacaine (0.5%) and 
buprenorphine (60 with bupivacaine (0.5%) for postoperative analgesia in 
caesarean section. Sixty parturient undergoing elective lower segment caesarean 
section (LACS) were randomly selected after dividing into two groups of 30 each. 
Control Group (C) received 1.70 ml ( 8.5mg) of bupivacaine (0.5%) while patients 
of study group (S) received 1.70 ml (8.5mg) bupivacaine 0.5%+(60 
buprenorphine. Onet  of analgesia was 5.35±1.79 min in control group, while 
1.85±1.39 min in study group (P<0.001). The total duration of analgesia was 
prolonged from 145.16±25.86 min in Control group to 491.26± 153.97 min in 
Study group. 

























MATERIALS AND METHODS 
The study was conducted at Government Kasturba Gandhi hospital for 
women and children, Chennai-5, in 60 patients undergoing elective lower segment 
caesarean section.  
Study design 
Prospective, Randomised, double blind study.  
Inclusion Criteria 
age  - 18 and above 
ASA - I and II patients 




not satisfying inclusion criteria 
Patients posted for emergency surgery 
Patients with bleeding diathesis 
Patients with local sepsis  
Platlet count < 1,00,000/µL 
Eclampsia 
Neurological deficits and Lack of written informed consent 
Consent 
The Institutional Ethical Committee approval and the patients’ consent were 
obtained prior to the study.  
 Preoperative evaluation 
 All the patients who were included in the study had a clinical examinations of 
their cardiovascular and respiratory system. The investigations done included 
Haemoglobin, Bleeding time, Clotting time, Blood Urea and sugar, Urine albumin 
and sugar to rule out any systemic illness. 
 The fourty patients were randomized into two groups consisting of twenty each 
namely study Group A and Group B. 
 Group A : Received bupivacaine and buprenorphine 
 (n=20) 
Group B : Received bupivacaine only  (n=20) 
 explained about the procedure to the patients and obtained informed consent. 
Premedication inj.ondensetran 8mg, inj.ranitidine 50mg intravenously given 30mins 
before surgery. The height, weight and Vital signs were recorded on the day of 
surgery. Each patients were taught about the Visual Analogue Pain Scale and were 
asked to indicate her level of pain on a 10 cm long Visual Analogue Pain Scale. The 
patients were shown a 10cm long horizontal scale marked from 0-10 and were told 
that 0 represented absolutely no pain and 10 represented the worst pain they can 
imagine. 
 Basic monitoring like pulse oxymeter, ECG, NIBP connected to the patient. 
Baseline status consisting of the Visual Analogue Score, Pulse rate, systolic and 
diastolic blood pressure, respiratory rate, oxygen saturation were recorded on 
arrival at operation theatre. Preloaded with 20ml/kg of lactated Ringers solution , 
prior to sub-arachnoid block. Under strict sterile aseptic precaution,after local 
infiltration with 2% lignocaine, sub-arachnoid block was performed with 25G 
quincke type spinal needle, with patient in right lateral decubitus position at L3-L4 
intervertebral space and hyperbaric 0.5% bupivacaine 1.7ml+ 0.2ml (60µg) of 
inj.buprenorphine in group A and 1.7ml of hyperbaric 0.5% bupivacaine + 0.9% 
normal saline 0.2ml in group B were given.    Following subarachnoid block, the 
patient was immediately placed in supine position, to prevent aortocaval 
compression left uterine displacement was done by keeping a wedge under right 
hip. O2 4L/min administered to all patients through simple face mask. Bladder 
catheterised routinely by surgeon.  
 Itraoperative hypotension was considered to be present , whenever systolic 
blood pressure decreased to less than 90mmHg or <20% of the baseline whichever 
appeared first and treated with ephedrine.bradycardia was to be treated with 
inj.atropine i.v0.02mg/kg ,if heart rate decresed to <60/min, and any fall in 
respiratory rate to less than ten per minute was noted.  
The following parameters were assessed in the operation theatre 
1. Pulse rate , blood pressure, Respiratory rate and oxygen saturation were 
monitored. 
2. Dermatomal sensory blockade to pin prick was evaluated and maximum level of 
sensory block was noted. 
3. Onset of sensory analgesia time noted. 
4. Onset of motor blockade time noted. 
5. Total duration of analgesia was recorded.  
6. Pain was evaluated by Visual Analogue Scale devised by Revill and Robinson 
(1976). VAS 0 – 10 cm 
0 – 2cm - No pain 
2 – 4 cm - Mild pain 
4 – 6 cm - Moderate pain 
6 – 8 cm - Severe pain 
8 – 10 cm - Worst pain 
If the patient is asleep, it is taken as no pain. Time of first demand analgesia was 
noted. 









0 Free movement of legs and feet , with ability to 
raise extended leg. 
None 
1 Inabilty to raise extended leg and knee flexion is 
decreased but full flexion of feet and ankles is 
present 
Partial 33% 
2 Inability to raise leg or flex knees, flexion at 
ankle and feet present 
Partial 66% 




 8. sedation score was noted intra-operatively and post-operatively 
Ramsay sedation score 
1 = Anxious , agitated and restlessness 
2 = Oriented and cooperative 
3 = Responds to command only 
4 = Brisk response to loud voice and glabellar tap 
5 = sluggish to NO response to light glabellar tap or loud auditory stimulus. 
 6 = No response to pain. 
9. Apgar score at 1min and 5min of delivery of the baby 
Total score of 8 to 10 = Normal 
Score of 4 to 7  = moderate impairment 
Score of 0 to 3  = needs immediate resuscitation.  
After completion of surgery patient was shifted to High Depedency Unit for 
observation and monitored postoperatively for 24 hours.  
 
 
 The following parameters were observed post-operatively:  
1. Pain assessment – VAS  
2. Sedation  
3. Pulse rate  
4. Blood pressure 
5. Respiratory rate 
6. Oxygen saturation  
7. Time of first demand analgesia- duration of analgesia  
8. Side effects like post operative nausea, vomiting, pruritus, respiratory  

























OBSERVATION AND RESULTS 
The study was conducted on a total of sixty patients to ASA I , II. They were 
divided into two groups of thirty each 
Group A : received 0.2 ml of buprenorphine (60µg) with 0.5% hyperbaric 
bupivacaine 1.7ml 
Group B : received 0.2 ml of Normal saline with 0.5% hyperbaricbupivacaine 1.7ml 
In both patients the volume of solution was kept constant 
Table 1 - Age Distribution  
 
Age  Case Group A Control Group B Total 
Number Percentage Number Percentage Number Percentage 
15 – 20 03 10.00 05 16.70 08 13.30 
20 – 25 13 43.30 16 53.30 29 48.30 
25 – 30 10 33.30 08 26.70 18 30.00 
30 – 35 03 10.00 01 03.30 04 06.70 
35 – 40 01 03.30 - - 01 01.70 




 Group-A Group-B 
Mean 25.57 24.73 
Sd 4.51 3.53 
t-value 0.80 
Df 58 
p-value  0.43 (Not Significant) 
The mean distribution of cases by age was observed and it shows statistically 

























AGE DISTRIBUTION  
Case Group Control Group
  
Table 2 - Weight Distribution 
 
Weight  Case Group A Control Group B 
Number Percentage Number Percentage 
40 – 50 3 10.00 0 - 
50 – 60 5 16.70 5 16.70 
60 – 70 18 60.00 22 73.30 
70 – 80 03 10.00 03 10.00 
80 – 90 01 03.70 0 0 





















WEIGHT DISTRIBUTION  
Case Group Control Group
 Case Group A Control Group B 
Mean 64.57 65.90 
Sd 8.40 4.74 
t-value 0.76 
Df 58 
p-value  0.45 ( Not Significant ) 
The mean distribution of cases by weight was observed to be statistically not 
significant between the groups A and B. 
 
 
Table 3 : Height Distribution 
 
Height   Case Group Control Group 
Number Percentage Number Percentage 
140 – 145 02 06.70 - - 
145 – 150 01 03.30 02 06.70 
150 – 155 11 36.70 11 36.70 
155 – 160 15 50.00 15 50.00 
160 – 165 01 03.30 02 06.70 
Total 30 100 30 100 
 
 
 Case Group Control Group 
Mean 154.97 155.93 
Sd 4.36 3.41 
t-value 0.96 
Df 58 
p-value  0.34 ( Not Significant ) 
 
 
The mean distribution of cases by height was observed to be statistically not 






























Case Group Control Group
Table-4 Diagnosis 
 
Diagnosis  Case Group Control Group 
Number Percentage Number Percentage 
Elderly primi 1 3.30 0 - 
G2/mobile head 1 3.30 1 3.30 
G2/Polyhydramnios 0 - 1 3.30 
G2/twin pregnancy 1 3.30 0 - 
G2P2/BREECH 2 6.70 0 - 
previous lscs 11 36.70 17 56.70 
previous lscs/anaemi 2 6.70 3 10.00 
previous lscs/PIH 2 6.70 0 - 
Primi 1 3.30 0 - 
primi/bigbaby 0 - 1 3.30 
primi/breech 2 6.70 0 - 
primi/mobile head 3 10.00 2 6.70 
primi/oligohydramnio 1 3.30 1 3.30 
primi/PIH 1 3.30 4 13.30 
primi/polyhydramnios 1 3.30 0 - 
primi/short stature 1 3.30 0 - 









ASA Case Group Control Group 
Number Percentage Number Percentage 
I 24 80.00 22 73.30 
II 6 20.00 8 26.70 
Total 30 100 30 100 
Chisqure 0.37 
Df 1 
p-value 0.54 (Not Significant) 
 



























 Case Group Control Group 
Mean 7.90 7.77 
Sd 0.31 0.43 
t-value 1.39 
Df 58 
p-value  0.17 (Not Significant ) 
 





 Case Group 






Pulse 81.07 ± 5.55  78.93 ± 5.72  1.47 0.15* 
RR 13.67 ± 1.49  15.40 ± 1.98  3.83  0.000 
Systolic B P 123.53 ± 10.94  128.47 ± 8.40  1.96 0.05 
Diastolic B P 74.87 ± 9.24   79.47 ± 9.23  1.93 0.06* 
MAP  88.67 ± 18.40   95.80 ± 8.05  1.47 0.06* 
SPO2  99.00 ± 00.00   99.00 ± 0.00    
* - Not Significant  
The preoperative VAS score, base line vital signs i.e. pulse rate, systolic ,diastolis 
blood pressure, respiratory rate, oxygen saturation were monitored and tabulated. 





 Effects of buprenorphine on the heart rate, respiratory rate and mean arterial 
pressure in the intraoperative and postoperative period monitored . in both groups 
haemodynamic stability was maintained to near normal and statistically not 






















Case Group Control Group
Table-8 
Pulse 
 Case Group 






 PRE 80.60 ± 5.71 78.93 ± 5.72 1.13 0.26* 
 0 Mint 81.87 ± 6.54 81.20 ± 5.29 0.43 0.67* 
 1 Mint 84.17 ± 9.44 83.13 ± 6.88 0.48 0.63* 
 3 Mint 85.00 ± 9.75  85.73 ± 6.66 0.34 0.74* 
 5 Mint  85.43 ± 11.51  86.20 ± 6.84 0.31 0.76* 
 10 Mint 86.83 ± 13.11 88.73 ± 6.05 0.72 0.47* 
 15 Mint 89.07 ± 10.96 89.00 ± 5.00 0.03 0.98* 
 30 Mint 85.33 ± 9.83 88.67 ± 4.99 0.46 0.65* 
 45 Mint 85.33 ± 9.30 86.27 ± 5.98 0.46 0.65* 
 1.00 Hour 82.60 ± 8.14 85.13 ± 5.11 1.44 0.15* 
 1.30 Hours  81.93 ± 6.38 82.93 ± 5.35 0.66 0.51* 
 2.00 Hours 80.67 ± 6.77 83.30 ± 5.39 1.98 0 .05 
 3.00 Hours 80.33 ± 5.73 82.93 ± 4.29 1.98 0.05 
 4.00 Hours 80.67 ± 5.90 81.27 ± 5.24 0.42 0.68* 
 5.00 Hours  80.60 ± 5.44 76.40 ± 6.00 2.84 0.01 
 6.00 Hours 79.87 ± 5.58 75.97 ± 5.89 2.63 0.01 
 8.00 Hours 81.07 ± 4.72 75.07 ± 5.96 4.32 0.000 
 12.00 Hours 81.20 ± 5.27 75.20 ± 4.63 4.69 0.000 
 24.00 Hours  80.67 ± 5.59 75.27 ± 4.88 3.98 0.000 
* - Not Significant  
  


















PULSE CHANGES  
Case Group Control Group
Table-9 
RR 
 Case Group 






 PRE 13.73 ± 1.46  15.40 ± 1.98  3.72 0.000 
 0 Mint 13.67 ± 1.49  15.73 ± 1.87  4.72 0.000 
 1 Mint 13.53 ± 1.63  15.60 ± 2.13  4.22 0.000 
 3 Mint 14.27 ± 1.64  15.93 ± 2.26  3.27 0.002 
 5 Mint  14.87 ± 1.55  16.07 ± 2.13  2.49 0.02 
 10 Mint 14.20 ± 1.61  16.00 ± 2.17  3.66 0.001 
 15 Mint 14.27 ± 1.64  15.80 ± 1.99  3.26 0.002 
 30 Mint 14.40 ± 1.33  15.80 ± 1.85  3.37 0.001 
 45 Mint 14.20 ± 1.42  16.47 ± 1.72  5.57 0.000 
 1.00 Hour 14.00 ± 1.49  15.80 ± 2.12  3.80 0.000 
 1.30 Hours  13.93 ± 1.70  15.93 ± 1.93  4.26 0.000 
 2.00 Hours 13.93 ± 1.78  16.20 ± 1.77  4.95 0.000 
 3.00 Hours 13.93 ± 1.53  16.33 ± 1.67  5.81 0.000 
 4.00 Hours 13.73 ± 1.36  15.27 ± 1.44  4.24 0.000 
 5.00 Hours  13.60 ± 1.22  15.07 ± 1.36  4.39 0.000 
 6.00 Hours 14.27 ± 1.55  14.73 ± 1.44  1.20 0.23 
 8.00 Hours 14.00 ± 1.66  15.03 ± 1.71  2.37 0.02 
 12.00 Hours 14.33 ± 1.18  15.40 ± 1.91  2.61 0.01 
 24.00 Hours  14.60 ± 1.19  15.53 ± 1.94  2.24 0.03 
* - Not Significant  
There was reduced respiratory rate in study group when compared to control group 
which is statistically significant.  
Table-10 
 
Systolic Blood Pressure (SBP) 
 
 Case Group 
Mean ± sd 
Control Group 
Mean ± sd 
t-value p-Value 
df=58 
 PRE 123.20 ± 
11.20  
128.47 ± 8.40  2.06 0.04 
 0 Mint 118.40 ± 8.26  123.53 ± 7.89  2.46 0.02 
 1 Mint 112.47 ± 7.22  115.40 ± 7.67  1.53 0.13* 
 3 Mint 109.80 ± 8.54  112.37 ± 7.71  1.22 0.23* 
 5 Mint  110.40 ± 6.98  109.83 ± 8.15  0.29 0.77* 
 10 Mint 109.93 ± 9.01  108.13 ± 5.92  0.91 0.36* 
 15 Mint 108.53 ± 6.43  105.40 ± 7.20  1.78 0.08 
 30 Mint 109.73 ± 7.37  108.07 ± 5.50  0.99 0.33* 
 45 Mint 110.33 ± 6.93  110.27 ± 4.16  0.05 0.96* 
 1.00 Hour 112.40 ± 6.65  112.13 ± 4.87  0.18 0.86* 
 1.30 Hours  112.53 ± 5.82  115.40 ± 6.06  1.87 0.07 
 2.00 Hours 114.27 ± 5.17  117.00 ± 5.35  2.01 0.05 
 3.00 Hours 114.73 ± 5.50  119.20 ± 6.76  2.81 0.01 
 4.00 Hours 115.40 ± 6.11  119.60 ± 6.94  2.49  0.02 
 5.00 Hours  117.20 ± 5.52  119.07 ± 5.84  1.27 0.21* 
 6.00 Hours 116.60 ± 6.61  119.53 ± 6.10  1.79 0.08* 
 8.00 Hours 118.40 ± 6.20  120.00 ± 6.95  0.94 0.35* 
 12.00 Hours 121.13 ± 6.82  120.53 ± 6.32  0.35 0.73* 
 24.00 Hours  122.00 ± 6.24  120.67 ± 7.03  0.78 0.44* 




















T I M E  





















T I M E  
DIASTOLIC BLOOD PRESSURE  
Case Group Control Group
 Table-11 
Diastolic Blood Pressure 
 
 Case Group 






 PRE 75.20 ± 8.86  82.87 ± 14.97  2.41 0.02 
 0 Mint 71.40 ± 7.65  76.00 ± 9.57  2.06 0.04 
 1 Mint 67.93 ± 7.71  69.73 ± 7.39  0.92  0.36* 
 3 Mint 64.47 ± 9.65  67.27 ± 8.13  1.22  0.23* 
 5 Mint  66.00 ± 7.68  64.20 ± 7.25  0.93  0.35* 
 10 Mint 62.93 ± 8.56  60.73 ± 8.43  1.00  0.32* 
 15 Mint 63.13 ± 8.48  58.27 ± 7.22  2.39 0.02 
 30 Mint 61.93 ± 7.85  57.93 ± 5.67  2.26 0.03 
 45 Mint 63.33 ± 8.11  61.73 ± 5.60  0.89  0.38* 
 1.00 Hour 64.67 ± 6.88  65.00 ± 5.70  0.20  0.84* 
 1.30 Hours  64.93 ± 5.98  67.53 ± 6.53  1.61  0.11* 
 2.00 Hours 67.67 ± 7.36  70.60 ± 6.44  1.64  0.11* 
 3.00 Hours 68.33 ± 7.03  73.13 ± 6.14  2.82 0.01 
 4.00 Hours 69.40 ± 7.13  72.93 ± 5.96  2.82 0.01 
 5.00 Hours  70.40 ± 6.98  73.33 ± 5.16  2.08 0.04 
 6.00 Hours 70.20 ± 6.67 72.73 ± 6.25  1.85  0.07* 
 8.00 Hours 70.33 ± 5.15  71.67 ± 7.37  1.52  0.13* 
 12.00 Hours 71.20 ± 6.23  71.73 ±5.38  0.81  0.42* 
 24.00 Hours  71.87 ± 6.79  71.47 ± 5.75  0.36  0.72* 


















T I M E 
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 Case Group 
Mean ± sd 
Control Group 
Mean ± sd 
t-value p-Value 
df=58 
 PRE 91.20 ± 8.83  96.20 ± 10.24  2.03 0.05 
 0 Mint 87.07 ± 6.98  91.84 ± 8.02  2.46 0.02 
 1 Mint 82.78 ± 6.59  84.96 ± 6.55  1.28  0.20* 
 3 Mint 79.58 ± 8.63  82.30 ± 7.10  1.33  0.19* 
 5 Mint  80.80 ± 6.68  79.41 ± 6.54  0.81  0.42* 
 10 Mint 78.60 ± 7.93  76.53 ± 6.48  1.11  0.27* 
 15 Mint 78.27 ± 7.40  73.98 ± 5.71  2.51 0.02 
 30 Mint 77.87 ± 6.77  74.64 ± 5.17  2.07 0.04 
 45 Mint 79.00 ± 7.24  77.90 ± 3.97  0.73  0.47* 
 1.00 Hour 80.58 ± 6.02  80.71 ± 4.82  0.09  0.92* 
 1.30 Hours  80.80 ± 5.31  83.49 ± 5.54  1.92  0.06* 
 2.00 Hours 83.20 ± 5.69  86.07 ± 5.66  1.96 0.05 
 3.00 Hours 83.80 ±5.66  88.49 ± 5.74  3.26  0.002 
 4.00 Hours 84.73 ± 5.82  88.49 ± 5.25  2.63 0.01 
 5.00 Hours  86.00 ± 5.58  88.58 ± 4.62  1.95  0.06* 
 6.00 Hours 85.67 ± 5.77  88.33 ± 5.31  1.86  0.07* 
 8.00 Hours 86.36 ± 4.73  87.78 ± 6.58  0.96 0.34* 
 12.00 Hours 87.84 ± 5.75  88.00 ± 4.63  0.12 0.91* 
 24.00 Hours  88.87 ± 5.54  88.53 ± 5.07  0.24 0.81* 
* - Not Significant  
Systolic, diastolic blood pressure and MAP for 24 hours are tabulated above. 
There was statistically no significant difference between study and control group. 
 
Table-13 mean VAS score between study and control group for 24 hours 
during the intraoperative and postoperative period. 
 Case Group 






 0 Hour 7.83 ± 0.38  7.77 ± 0.43  0.64 0.07 
 1 Hour - - -  
 2 Hours - 0.40 ±0.72 3.03 0.004 
 3 Hours  0.00 2.40 ± 0.81 16.16 0.000 
 4 Hours 0.00 2.80 ± 0.61 25.13 0.000 
 5 Hours 0.00  3.17 ± 0.91 19.00 0.000 
 6 Hours 0.17 ± 0.38 3.60 ± 1.00 17.53 0.000 
 8 Hours 1.10 ± 1.03 3.70 ± 0.79 10.96 0.000 
 10 Hours 1.70 ± 0.83 3.90 ± 1.06 8.91 0.000 
 12 Hours  1.80 ± 0.85 3.87 ± 1.07 8.91 0.000 
 16 Hours 1.40 ± 0.50 4.37 ± 1.03 14.16 0.000 
 20 Hours 1.53 ± 0.09 4.13 ± 1.14 11.44 0.000 
 24 Hours 1.73 ± 0.45 4.10 ± 1.16 10.46 0.000 
* - Not Significant  
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Case Group
 Table-14 RAMSAY SEDATION SCORE 
 
 Case Group 






 0 Hour 1.00 ± 0.00  1.00 ± 0.00 - - 
 1 Hour 2.00 ± 0.00 2.00 ± 0.00 - - 
 2 Hours 2.03 ± 0.18  2.00 ± 0.00 1.00  0.32* 
 3 Hours  2.03 ± 0.18  1.87 ± 0.35  2.34 0.02 
 4 Hours 2.07 ± 0.25  1.60 ± 0.50  4.57 0.000 
 5 Hours 2.07 ± 0.25  1.57 ± 0.50  4.85 0.000 
 6 Hours 2.10 ± 0.31  1.83 ± 0.38  3.00 0.004 
 8 Hours 2.10 ± 0.31  1.67 ± 0.48  4.18 0.000 
 10 Hours 2.07 ± 0.25  1.73 ± 0.45  3.54 0.001 
 12 Hours  2.07 ± 0.25  1.73 ± 0.45  3.54 0.001 
 16 Hours 2.03 ± 0.18  1.70 ± 0.47  3.65 0.001 
 20 Hours 2.00 ± 0.00  1.87 ± 0.35  2.11 0.04 
 24 Hours 2.00 ± 0.00  2.00 ± 0.00  - - 
* - Not Significant  
Study group patients show increased sedation score which is statistically significant 








ONSET OF SENSORY ANALGESIA 
 
 Case Group Control Group 
Mean 93.43 206.20 
Sd 32.58 40.06 
Range 50 - 192 135 – 312 
t-value 11.96 
Df 58 
p-value  0.000 (Significant) 
The mean duration of onset of sensory analgesia in study group is 
93.43±SD32.58 seconds. the mean duration in control group is 206.20±SD40.06 
seconds. When compared to control group study group patients have increased 






















Onset of motor blockade 
 
 Case Group Control Group 
Mean 164.03 259.83 
Sd  62.11 38.05 
Range 70 – 300 180 -360 
t-value 7.20 
Df 58 


















Motor Onset  
 Onset of motor blockade in study group is 164.03 seconds with SD 62.11 
seconds. In control group mean is 259.83seconds with SD 38.05 seconds.Onset of 
motor blockade is earlier in study group which is statistically significant when 




 Case Group Control Group 
Mean 659.63 190.70 
Sd 96.33 22.86 
Range 455 - 815 152 – 275 
t-value 25.94 
Df 58 
p-value  0.000 (Significant) 
 
Total duration of analgesia in study group is 659.63±96.33 minutes. In control 
group is 190.70±22.86 minutes.Duration of analgesia is prolonged in study group 





 Case Group 






 1 Mint 7.70 ± 0.60  7.37 ± 0.62  2.13 0.04 
 5 Mint 8.87 ± 0.35  8.83 ± 0.38  0.36  0.72* 


















Analgesia Duration  
 1minute Apgar score in study case is 7.70±0.60. in control 7.37±0.62 which is 
significant. But in 5 minute Apgar score in study case 8.87±0.35 and in control case 





















APGR Score  









































Case Group Control Group
Table -19  
Complications 
 
Complications Case Group Control Group 
Number Percentage Number Percentage 
No 
Complication 
19 63.31 23 76.70 
Ponv 6 20.00 4 13.30 
Pruritus 0 - 0 - 
Hypotension 1  3.30 2 6.70 
Drowsiness 4 13.30 0 - 
Respiratory 
Depression  
0 - 0 - 
Ponv & 
Hypotension 
0 - 1 3.30 
Chi-square 6.11 
Df 4 
p-value 0.19 (Not Significant) 
 
 
 6 patients(20%) in study group and 4(13.30) patients in control group 
has PONV. 13.30% of patients in study group has drowsiness.   

























 Any method of postoperative analgesia must be simple and safe. Also it 
should be clinically appropriate and evidence based. But most of the patients using 
intramuscular or intravenous opioid drugs are left with unrelieved pain. 
 
 Nowadays Spinal anaesthesia has become the preferred technique of 
choice for patients undergoing cesarean section. Because it is a simple reliable and 
easier technique to perform and provide rapid onset of the dense blockade, results in 
reduced need of supplemental IV analgesics. 
 Pregnant patients require small dose of spinal local anaesthetics due to 
(i) smaller volume of CSF, (ii) cephalad movement of hyperbaric local anaesthetics 
in supine position, (iii) greater sensitivity of nerve fibres.  
 
 Adjuvants like opioids improve the quality of intraoperative anaesthesia, 
prolong the postoperative analgesia and reduce the dose and side effects of local 
anaesthetics. 
 
 Wang et al.,(1979) the first clinician used opioids intrathecally in man. 
Addition of opioids in spinal to the pregnant patients coming for caesarean section, 
decreases the incidences of hypotension and exaggerated sympathetic block is 
absent. Hence during the postoperative period patients can ambulate early , mother 
can breast feed their child effectively and hence effective bonding between the 
mother and child will occur. 
 
 Buprenorphine is a mixed agonist – antagonist type of opioid drug. It is 
highly lipid soluble, has high affinity for opioid receptor, prolonged duration of 
action. During pregnancy there is increased chance of thromboembolic disease, so 
good postoperative pain relief provided by intrathecal buprenorphine improve early 
mobilization thereby reduce the chance of thromboembolism. 
 
 In our study we used intrathecal buprenorphine as postoperative pain 
relief drug in patients undergoing elective cesarean section. sixty patients are 
divided randomly into two groups(30 each). GroupA received 1.7ml of hyperbaric 
0.5% bupivacaine with 0.2 ml (60µg) of buprenorphine and GroupB received 1.7ml 
of hyperbaric 0.5% bupivacaine with 0.2ml of 0.9% normal saline. 
 Sarvella et al., demonstrated that low dose spinal bupivacaine 9mg with 
fentanyl 20µg provide satisfactory analgesia in cesarean section. In the study of 
sunil dixit et al., 
 
 Buprenorphine increses onset of sensory block without affecting motor 
blockade and hemodynaemic changes. In our study onset of sensory analgesia is 
significantly earlier ie., 1-3 mins. In dixit et al., study onset of analgesia in study 
group is 1.85±1.39min. this is due to high lipid solubility and high affinity for 
opioid receptors. 
 
 The drug required during the postoperative period is less than that 
required when they are treated prophylactically. In pregnancy lesser amount of drug 
will produce profound analgesia because of increased sensitivity of nerve fibres. In 
our study the amount of drug required is 60µg. 
 
 In our study, all the patients were comfortable intraoperatively and with 
in the first two hour of postoperative period. From third hour onwards half of the 
patients in control group VAS score is more than three and demanded analgesia.in 
twentyfour hours period requirement of resque analgesia in control group is more 
than three times. 
 In study group during the first six hours almost all the patients are 
comfortable and VAS is 0. Upto eight hour period three patients demanded 
analgesia. In tenth hour five patients demanded analgesia and in twelveth hour eight 
patients needed analgesia. And fifteen patients required no analgesia during the 
24hour period. All the patients required one dose of resque analgesia only. 
 
 The mean duration of analgesia in our study is 659.63±96.33 min. 
according to safia et al., mean duration of analgesia with buprenorphine 1µg/kg is 
475.6±93.7 min. according to Lipp et al., upto thirteen hours of analgesia with 
0.15mg of intrathecal buprenorphine. According to sunil dixit et al., mean duration 
of analgesia is 491.26±153.97min. with G.Capogna et al study(1988) mean duration 
of analgesia with 0.045mg of buprenorphine is 7 to 12 hours. Our study correlates 
with capogna et al., 
 
 Capogna et al., suggested duration of analgesia is dose dependent and 
buprenorphine increases the duration of analgesia in our study. 
 
 Buprenorphine has prolonged duration of action , is due to complex 
receptor kinetics. Buprenorphine has high affinity to opiate receptors. It forms avid 
complex with the receptor , tend to persist for long duration of period. The opiate 
receptor affinity for buprenorphine is 50 times more than that of morphine. 
 
 The high lipid solubility and high affinity for opiate receptors of 
buprenorphine explains buprenorphine’s longer duration of action when compared 
to other lipid soluble drugs like fentanyl which produces short lived analgesia due 
to rapid clearance from spinal cord sites. 
 
 Intraoperatively quality of analgesia was excellent in study group . 
visceral pain or tractional pain , pain during exteriorization of uterus was obtunded 
due to favourable properties of opiate receptors.(Shah etal.,). 
 
 The major side effects of buprenorphine seen in our study was 
drowsiness and postoperative nausea and vomiting. 
 
 Four patients in our study group was in the state of drowsy but all the 
patients are arousable easily. 
 
 Delayed respiratory depression is a known side effect of buprenorphine. 
Early respiratory depression occurs within one hour , due to increased vascular 
uptake and is transient.(Bromage etal.,) . Delayed respiratory depression is more 
intense and prolonged. 
 
 Respiratory depression is due to cephalad spread of opioids in the CSF 
and reaches opiate receptors which is located in ventral pons medulla. In study of 
Capogna etal., there was no respiratory depression in any of his cases received 
intrathecal buprenorphine. According to Harcus etal., the drug associated 
respiratory depression was estimated tobe less than 1%. Also in the studies of Safia 
etal., sunil dixit etal., there was no respiratory depression in their study cases. Our 
study correlates with Capogna etal., safiaetal., sunil dixit etal., 
 
 Water soluble drugs like morphine produce more respiratory depression 
than other lipid soluble opioids. 
 
 Nausea and vomiting is due to rostral spread of opioid in CSF to 
intrathecal structures including vomiting centre and chemoreceptor trigger zone in 
the vascularized area postrema in the floor of fourth ventricle. 
 
 Incidence of post operative nausea and vomiting is none to 20% in 
studies done by Dixit etal., Lanz etal., Sen etal., Safiya etal., 
 In our study incidence of postoperative nausea and vomiting in study 
group is 20% and control group 13.3%. our study correlates with Dixit etal., safiya 
etal., all the patients relieved by inj. Ondensetran 8mg intravenously. 
 
 Sedation score according to Ramsay Sedation Score scale of 1-6 
measured in postoperatively. When compared with control group, study group 
patients has statistically significant sedation score. Four patients had a sedation 
score of three in study group upto eight to sixteen hours . 
 
 Facial pruritus by opioids is due to rapid penetration of opioids to caudal 
portion of the nucleus of the spinal tract of trigeminal nerve. According to Sunil 
dixit etal., safiya etal., there was no cases reported of facial pruritus. In our study 
group no cases of pruritus reported. Study correlates with Sunil dixit etal., safiya 
etal., 
 
 There was no significant changes in hemidynamic variability both in 
study group and control group during intraoperative and postoperative period. In 
our study intraoperative complications like hypotension and bradycardia in both 
groups are comparable and statistically insignificant. There was no significant 
requirement of crystalloid and ephedrine hydrochloride. According to Sunil dixit 
etal., saxena etal., Capogna etal., there was no significant changes in pulse rate BP 
and respiratory rate attributable to spinal buprenorphine. Our study correlates with 
Sunil dixit atal., capogna etal., saxena etal., 
 
 Apgar score was used to monitor neonatal wellbeing after birth during 
1min and 5min interval period. The pediatrician could not able to find any 
significant differences between study and control group after 5min. intrathecal 
opioids are associated with less neonatal drug transfer than any other method , 
given that smaller doses are used for intrathecal administration. Johnson k., study 
finds 5minutes Apgar Score was highly predictive of respiratory distress syndrome. 
 
 In our study the drug buprenorphine is chosen because it is easily 
available and highly lipophilic drug . so the drug can diffuse from CSF to neuraxis 
faster and less duration of stay in CSF . there is less likelihood of rostral spread 
hence less chance of respiratory depression. So it was decided to compare the 
quality and duration of postoperative analgesia provided by buprenorphine. 
  The route of administration of additives in our study was by single shot 
subarachnoid injection. Subarachnoid block procedure is commonly done in 
anaesthetic practice and easier technique when compared to epidural technique. 
 
  None of the patient has exhibited any untoward serious cardiovascular 
respiratory and CNS effects and none of the babies affected, which proved that 
buprenorphine is safe and suitable agent for postoperative pain relief by intrathecal 
route. When longer duration of post operative pain relief is needed buprenorphine 
can be a suitable drug for pregnant patients because of prolonged duration of action. 
 
 Spinal opiate analgesia is better than any other route because smaller 
dose is sufficient , thereby reducing the side effects and patients are not unduly 
sedated and the duration of analgesia is longer than the parenteral route thereby 
repeated injections are avoided. 
 
 Spinal opiates better than spinal local anaesthetics in that there is no 
motor blockade and less haemodynamic changes. The optimal dose of intrathecal 
administration is lesser than the dose for epidural route. 
 
 The addition of buprenorphine to local anaesthetics has not interfered 
with its action like duration of action , quality of motor and sensory blockade , 
quality of analgesia or incidence of intraoperative and post operative complications 
like bradycardia, hypotension, nausea, vomiting is considered. 
 
 Buprenorphine has a definite edge over morphine because better 
concentration are achieved in the spinal cord and very little amount is left in CSF. 
 
 A single intrathecal buprenorphine with bupivacaine has produced not 
only a satisfactory intraoperative anaesthesia but prolonged duration of analgesia 
during the postoperative period upto 13-14hours of duration. Thereby avoiding the 
repeated intramuscular or intravenous injections and also improve morale of the 
patient. 
 
 Buprenorphine 60µg with hyperbaric 0.5% bupivacaine 1.7ml is safe , 
cheap and provides good and prolonged duration of postoperative analgesia without 
any significant maternal and neonatal side effects.  
 
 But according to Stoelting the patients receiving intrathecal opioids 
should be under close monitoring for adequacy of breathing but suggests that low 
dose neuraxial adminiatration of narcotics as in our study does not obligate 



















 A clinical study was done to evaluate the efficacy , duration of post 
operative pain relief and to know the quality of analgesia provided by intrathecal 
opioids added to local anaesthetic agents. 
 The study was undertaken in 60 patients of ASA I and II posted for 
elective cesarean section for post operative pain relief.  
 
GroupA – 30 patients – received 1.7ml of hyperbaric 0.5% bupivacaine with 
buprenorphine 0.2ml(60µg).  
GroupB – 30 patients – received 1.7ml of hyperbaric 0.5%bupivacaine  
with 0.2ml 0f 0.9% normal saline. 
 
- Onset of sensory analgesia is significantly increased(1-31/2min) in patients 
receiving buprenorphine than control group. 
- Onset of motor blockade also significantly increased in study group 1-5min.  
- Postoperative analgesia was upto 13-14hours in groupA(study)with 
SD.96.33min than control group B 21/2 – 41/2 hours. 
- There was no statistically significant changes in pulse rate, respiratory rate, 
blood pressure , oxygen saturation and neonatal apgar score. 
 - There was no respiratory depression in study group and few patients had a 
sedation score >3 which is statistically significant. There was no statistically 































 Intrathecal buprenorphine is suitable drug for postoperative analgesia in 
patients undergoing cesarean section, it enhances onset of sensory blockade without 
affecting motor blockade and sympathetic activity. Anaesthesia was superior when 
buprenorphine is mixed with bupivacaine (0.5%) as compared to bupivacaine alone. 
The benefits of opiates are significant when used intrathecally and outweighs the 
side effects. Subarachnoid block is easy to perform , more predictable and the drug 
is easily available. So this combination of drugs can be used for postoperative 
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NAME:                                                           AGE : 
IP NO:                                                             SEX :                                                             DIAGNOSIS  :                                  
ASA/MMS:                                                                                                                           SURGERY      :                                                                                                         
Group :                                                           Height:                                                           Weight : 
Preoperative assessment: 
H/o HT/DM/IHD/EPILEPSY/TB/ALLERGY 
H/o PREVIOUS SURGERY/ ANAESTHESIA 
GENERAL EXAMINATION 
Nutritional status/ Pallor/Hydration/icterus/cyanosis/clubbing/pedal oedema 
 
BASE LINE VITAL SIGNS 
Pulse rate   : 
Blood pressure : 
Respiratory rate : 
Temperature  : 
SYSTEMIC EXAMINATION 
CVS :    RS:   PA:   CNS: 
 
INVESTIGATION 
Hb%/ PCV  : 
Blood group  : 
Blood urea  : 
 Sugar  : 
Serum creatinine : 
Urine Routine : Albumin/sugar 
Bleeding time : 
Clotting time : 
ANAESTHESIA TECHNIQUE : 
 








Pre op           
Spinal 0MIN          
 1MIN          
 3MIN          
 5MIN          
 10MIN          
 15MIN          
 20MIN          
 25MIN          
 30MIN          
 35MIN          
 40MIN          
 45MIN          
 60MIN          
 1 1/2HR          
 2HR          
 3HR          
 4HR          
 5HR          
 6HR          
 8HR           
 12HR          
 24HR          
 
NEONATAL APGAR SCORE 
 
         1MIN  














EVENTS                        TIME 
 ONSET OF SENSORY ANALGESIA                                                                                                   
ONSET OF MOTOR BLOCKADE  
SURGICAL INCISION  
SKIN INCISION TO BABY DELIVERY  
UTERUS CLOSURE  
END OF SURGRY  
ONSET OF PAIN (VAS-3)  
SIDE EFFECTS Yes/no TREATMENT REMARKS 
PONV    
PRURITUS    
HYPOTENSION    
BRADYCARDIA    
DROWSINESS    
RESPIRATORY 
DEPRESSION 
   
 STUDY GROUP-A 
S.NO NAME AGE SEX WEIGHT HEIGHT DIAGNOSIS ASA DRUG RSS VAS PULSE RR SBP DBP MAP SPO2 
1 SANDHYA 24 FEMALE 68 156 previous lscs 1 1 1 8 86 14 100 62 2 99 
2 kalpana 22 FEMALE 64 158 G2/mobile head 1 1 1 8 80 12 120 84 96 99 
3 Roopavathy 25 FEMALE 68 155 previous lscs 1 1 1 8 82 14 138 86 103.3333 99 
4 sathya 21 FEMALE 68 160 primi 1 1 1 8 80 12 130 84 99.33333 99 
5 kalaiselvi 30 FEMALE 64 156 previous lscs 1 1 1 7 86 14 120 70 86.66667 99 
6 Hepsiba 20 FEMALE 67 150 primi/mobile head 1 1 1 7 88 16 120 80 93.33333 99 
7 Jaffni 21 FEMALE 50 156 primi/breech 1 1 1 8 88 12 122 80 94 99 
8 Shanthi 27 FEMALE 60 152 G2/twin pregnancy 1 1 1 8 72 16 112 68 82.66667 99 
9 Gomathy 21 FEMALE 62 156 previous lscs/anaemia 2 1 1 8 78 14 118 64 82 99 
10 Afrose 28 FEMALE 68 155 previous lscs 1 1 1 8 80 14 112 80 90.66667 99 
11 Lalitha 28 FEMALE 88 155 previous lscs 1 1 1 8 82 12 130 80 96.66667 99 
12 Sathya 26 FEMALE 56 142 primi/oligohydramnios 1 1 1 8 74 14 126 84 98 99 
13 Jeevitha 21 FEMALE 65 158 primi/polyhydramnios 1 1 1 8 82 14 114 80 91.33333 99 
14 Kalaivani 30 FEMALE 62 154 primi/PIH 2 1 1 8 78 12 130 70 90 99 
15 Shenbagavalli 31 FEMALE 78 162 previous lscs 1 1 1 8 78 14 120 70 86.66667 99 
16 Kannagi 26 FEMALE 74 160 previous lscs 1 1 1 8 72 12 110 70 83.33333 99 
17 Renuka 26 FEMALE 67 158 G2P2/BREECH 1 1 1 8 88 14 130 80 96.66667 99 
18 Sugapriya 21 FEMALE 60 158 primi/breech 1 1 1 7 92 16 140 80 100 99 
19 Kalaivani 37 FEMALE 58 157 previous lscs 1 1 1 8 72 14 138 86 103.3333 99 
20 shyamala 20 FEMALE 48 153 primi/mobile head 1 1 1 8 84 14 130 70 90 99 
21 Durgadevi 20 FEMALE 65 158 G2P2/BREECH 1 1 1 8 78 16 130 80 96.66667 99 
22 Kannika 30 FEMALE 62 153 previous lscs 1 1 1 8 78 12 122 74 90 99 
23 Lakshmi 23 FEMALE 47 144 primi/short stature 1 1 1 8 80 12 118 72 87.33333 99 
24 Vasanthi 24 FEMALE 68 152 primi/mobile head 1 1 1 8 86 16 112 62 78.66667 99 
25 Malathy 22 FEMALE 64 153 previous lscs 1 1 1 8 90 16 110 70 83.33333 99 
26 Banumathy 25 FEMALE 76 160 previous lscs 1 1 1 8 82 12 140 90 106.6667 99 
27 Vanitha 32 FEMALE 66 152 Elderly primi 2 1 1 8 72 12 150 90 110 99 
28 Vijayalaxmi 34 FEMALE 64 156 previous lscs/PIH 2 1 1 8 78 12 124 60 81.33333 99 
29 Divya 24 FEMALE 60 152 previous lscs/PIH 2 1 1 8 80 14 120 60 80 99 
30 Devi 28 FEMALE 70 158 previous lscs/anaemia 2 1 1 8 86 14 120 60 80 99 
 PULSE 
S.NO PRE 0MIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 86 90 88 72 68 97 98 86 90 88 90 84 82 80 84 80 80 82 82 
2 80 80 84 82 82 88 86 84 90 92 80 84 86 84 86 86 86 88 88 
3 82 86 88 96 96 94 94 94 90 84 80 82 80 86 80 84 84 80 80 
4 80 82 84 86 84 86 88 84 86 88 86 86 84 80 88 72 80 80 68 
5 86 88 94 92 94 86 90 92 90 88 86 84 86 86 82 70 80 86 86 
6 88 90 90 88 92 94 102 102 102 78 78 78 72 72 78 78 82 82 80 
7 88 86 114 110 74 78 76 78 94 92 90 80 84 84 86 80 92 88 84 
8 72 74 78 94 98 96 94 94 98 94 92 90 90 86 86 80 80 84 84 
9 78 82 90 76 76 94 94 92 90 86 80 80 82 86 86 88 84 88 86 
10 80 80 90 96 90 96 102 100 96 90 94 92 70 68 68 62 72 74 74 
11 82 88 92 94 102 104 100 82 84 82 84 82 92 90 82 82 80 80 80 
12 74 72 80 94 108 104 106 100 88 90 84 82 82 82 82 84 84 86 80 
13 82 82 84 80 94 98 96 82 84 82 82 80 82 82 84 80 80 80 80 
14 78 70 74 76 74 70 80 70 70 70 70 72 72 68 74 76 74 72 72 
15 78 80 80 82 82 86 82 86 88 88 82 76 78 80 80 80 82 80 80 
16 72 74 74 74 78 80 80 80 82 84 90 86 82 86 82 82 84 82 80 
17 88 90 92 92 98 96 96 92 90 84 80 80 84 86 82 84 84 80 82 
18 92 90 92 92 94 94 98 96 90 92 84 88 86 86 86 84 84 88 86 
19 72 74 69 74 69 60 86 92 84 86 86 84 82 84 80 80 84 82 82 
20 84 88 88 90 88 90 94 90 96 90 82 86 82 82 86 80 80 86 86 
21 78 74 74 70 70 64 68 68 98 80 82 86 86 86 86 86 86 86 86 
22 78 78 76 86 86 90 90 90 86 88 76 82 74 76 78 78 76 74 74 
23 80 88 86 88 90 92 94 84 76 74 80 72 76 80 82 82 80 84 88 
24 86 86 78 78 76 76 72 76 74 74 76 70 70 78 74 78 74 70 78 
25 90 90 96 94 104 104 104 86 70 64 68 62 72 72 70 70 68 74 70 
26 82 82 84 88 90 96 92 86 80 70 80 86 82 72 70 76 80 70 70 
27 72 76 78 70 70 60 68 68 70 72 74 78 76 74 80 86 84 82 82 
28 78 74 68 74 68 60 68 62 66 70 72 70 78 78 72 84 84 82 84 
29 80 88 86 88 90 92 94 84 76 74 80 72 76 80 82 82 80 84 88 
30 72 74 74 74 78 80 80 80 82 84 90 86 82 86 82 82 84 82 80 
  
RR 
S.NO PREOP OMIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 14 14 16 16 18 16 16 16 14 12 12 12 14 14 14 14 14 14 14 
2 12 16 16 16 16 16 16 16 16 16 14 14 14 14 14 14 14 16 16 
3 14 16 14 16 16 16 14 16 14 14 14 16 14 14 14 14 14 14 16 
4 12 14 12 12 14 14 16 14 14 14 14 14 16 14 16 18 18 16 16 
5 14 14 12 14 14 12 16 16 18 18 18 18 14 12 12 12 10 14 14 
6 16 16 16 16 16 16 16 14 14 14 12 12 14 14 14 14 14 14 14 
7 12 14 14 14 14 14 12 12 12 12 12 14 12 14 14 12 12 12 12 
8 16 16 16 18 18 16 18 14 14 14 14 12 14 14 12 16 12 12 14 
9 14 14 12 14 16 14 16 16 14 12 12 12 12 12 12 12 14 14 14 
10 14 14 16 16 14 14 14 14 12 14 16 14 14 14 14 14 14 16 16 
11 12 12 14 16 16 14 14 14 16 14 14 16 14 14 14 12 12 16 16 
12 14 12 12 12 14 14 12 14 14 12 12 12 12 12 12 16 14 16 14 
13 14 14 14 16 14 16 14 16 16 16 16 16 16 16 16 14 14 14 14 
14 12 14 14 14 16 14 14 14 14 14 12 14 14 14 14 16 16 16 16 
15 14 14 12 14 16 16 14 16 14 14 16 16 16 16 14 16 16 14 16 
16 14 12 12 14 16 16 14 16 14 14 16 16 16 16 14 16 16 14 16 
17 14 14 14 16 14 16 14 14 16 12 14 12 12 14 14 14 14 16 16 
18 16 16 16 16 16 12 14 14 16 16 16 16 16 14 14 14 14 14 14 
19 14 12 12 12 12 12 12 14 14 14 14 14 16 14 12 14 12 14 14 
20 14 14 12 12 16 16 16 16 14 14 12 12 12 14 14 14 14 14 16 
21 16 14 10 12 14 14 16 14 14 14 14 12 14 12 12 12 14 14 14 
22 12 12 14 12 12 12 14 12 12 14 12 12 12 12 14 14 14 14 14 
23 12 12 14 14 14 14 12 14 12 12 12 12 12 12 14 14 14 14 14 
24 16 16 14 14 12 12 16 14 14 14 12 14 12 12 12 14 14 14 14 
25 16 14 14 12 14 14 14 14 12 12 14 14 14 12 12 14 14 14 14 
26 12 12 14 14 16 14 14 14 14 14 14 14 14 12 12 12 12 14 14 
27 12 12 12 14 14 12 12 14 14 14 14 16 14 16 16 16 16 14 14 
28 12 12 12 14 14 12 12 12 16 16 16 14 16 14 14 14 12 12 12 
29 14 12 14 14 14 12 12 12 14 16 14 12 12 14 14 16 16 16 14 
30 14 12 12 14 16 16 14 16 14 14 16 16 16 16 14 16 16 14 16 
 SBP 
S.NO PREOP 0MIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 100 108 102 104 108 108 108 118 120 120 120 120 122 110 116 110 120 120 120 
2 120 120 110 100 100 100 102 104 104 102 104 110 112 110 110 104 110 110 120 
3 138 130 126 110 110 100 112 112 112 110 114 110 112 110 120 110 110 130 130 
4 130 118 116 116 110 118 110 108 110 110 110 110 110 120 120 124 120 120 120 
5 120 112 108 100 118 112 110 110 112 110 110 110 110 112 118 110 120 122 120 
6 120 110 104 100 110 112 110 112 102 110 112 110 110 110 110 110 118 118 116 
7 122 118 100 108 110 108 102 102 100 112 110 110 110 110 120 124 130 126 128 
8 112 116 104 108 100 102 100 106 104 110 110 120 120 126 122 116 120 120 124 
9 118 118 110 86 100 100 100 102 110 120 124 120 120 120 120 120 122 130 130 
10 112 110 100 100 100 100 104 100 110 110 110 116 126 120 120 120 124 124 126 
11 130 112 108 100 118 112 104 124 120 120 120 112 118 110 120 120 122 126 130 
12 126 118 108 120 100 106 104 100 110 110 110 120 120 130 126 126 120 134 130 
13 114 114 114 104 114 140 112 108 110 110 110 110 108 110 110 108 114 120 120 
14 130 130 110 110 104 100 100 104 120 124 114 122 120 126 124 126 120 128 128 
15 120 120 118 120 110 108 108 110 104 106 110 108 110 114 122 120 120 130 126 
16 110 110 110 110 112 106 110 108 100 104 104 112 110 110 110 110 114 114 120 
17 130 130 110 110 110 110 110 104 110 110 120 120 124 122 124 120 120 120 122 
18 140 138 118 120 110 100 130 128 120 120 120 120 120 120 120 118 122 120 120 
19 138 110 108 110 108 106 112 104 110 112 110 110 110 112 110 120 110 124 124 
20 130 120 120 122 120 122 118 118 116 118 120 122 124 120 120 120 124 120 120 
21 130 120 124 120 110 106 106 100 106 106 110 108 112 110 108 110 110 118 120 
22 122 120 122 120 122 122 110 106 110 110 112 108 110 110 116 110 120 120 120 
23 118 110 110 108 110 110 102 110 110 110 110 112 110 122 120 120 124 124 130 
24 112 114 114 104 104 104 110 114 120 120 120 120 120 122 124 128 124 120 120 
25 110 110 108 108 108 108 102 108 110 120 110 120 118 112 110 110 112 120 120 
26 140 136 120 116 110 116 120 120 118 130 124 120 110 118 120 124 120 110 110 
27 150 130 120 120 126 120 110 118 124 110 104 110 112 112 118 122 126 130 130 
28 124 120 120 110 116 114 110 120 108 108 110 118 112 114 120 118 122 120 110 
29 120 120 122 120 122 122 110 106 100 106 110 108 112 110 108 110 100 102 106 
30 110 110 110 110 112 106 110 108 100 104 104 112 110 110 110 110 114 114 120 
 
 DBP 
S.NO PREOP 0MIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 62 64 68 62 56 56 54 68 70 70 70 80 82 78 80 80 70 70 70 
2 84 76 70 64 60 56 60 60 64 60 60 68 70 60 62 60 60 66 68 
3 86 80 76 64 64 62 64 64 64 60 64 70 76 70 72 72 70 70 70 
4 84 58 58 60 62 58 70 70 70 64 62 60 60 60 64 64 62 62 62 
5 70 66 52 50 62 64 60 62 64 70 72 80 74 80 74 70 74 78 78 
6 80 62 60 50 68 64 60 54 52 62 62 60 62 68 70 60 74 70 70 
7 80 80 50 52 60 56 50 50 52 74 70 74 70 72 82 80 70 72 72 
8 68 70 56 56 56 58 52 54 60 62 60 60 60 70 64 70 68 70 70 
9 64 62 60 56 64 50 52 54 54 60 62 64 70 76 70 72 76 80 80 
10 80 80 68 50 56 50 56 58 62 60 62 64 68 80 74 70 74 80 80 
11 80 76 78 52 62 60 60 60 62 60 68 76 74 70 70 80 74 80 80 
12 84 72 66 86 54 60 66 64 64 60 64 60 70 80 84 80 80 74 70 
13 80 80 80 52 82 80 68 50 56 60 60 62 60 60 70 72 62 78 76 
14 70 72 70 64 62 60 54 64 66 62 64 66 72 70 72 70 72 70 70 
15 70 70 70 70 72 68 64 60 64 64 68 66 64 68 72 70 70 74 78 
16 70 70 72 72 74 68 68 64 56 62 60 70 70 68 64 60 68 60 60 
17 80 80 68 68 60 62 62 68 60 68 64 70 70 72 70 70 70 74 74 
18 80 80 70 70 70 56 84 70 70 72 72 70 74 74 70 68 74 76 78 
19 86 64 68 64 68 58 70 50 60 64 60 62 60 64 68 70 70 78 78 
20 70 70 70 74 70 74 74 76 80 80 76 80 80 80 80 78 76 70 70 
21 80 70 66 60 52 48 48 52 54 54 60 64 64 68 68 68 72 64 80 
22 74 74 76 74 76 74 70 68 60 62 64 62 68 60 70 70 74 74 70 
23 72 70 70 72 70 74 70 72 70 70 70 68 76 76 84 80 76 70 84 
24 62 62 66 60 66 60 62 68 80 82 76 80 70 70 70 76 70 74 64 
25 70 70 68 68 64 68 66 60 70 74 70 70 72 70 70 74 74 68 70 
26 90 90 86 84 80 80 80 80 80 70 76 80 74 62 62 68 70 70 70 
27 90 80 70 72 74 70 66 64 70 60 64 60 62 74 76 74 72 80 80 
28 60 60 66 64 72 72 58 58 58 56 54 58 52 52 54 60 60 60 62 
29 60 64 68 72 70 54 58 52 52 56 54 56 56 62 62 60 60 64 62 
30 70 70 72 72 74 68 68 64 56 62 60 70 70 68 64 60 68 60 60 
 
 MAP 
S.NO PREOP 0MIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 74.66667 78.66667 79.33333 76 73.33333 73.33333 72 84.66667 86.66667 86.66667 86.66667 93.33333 95.33333 88.66667 92 90 86.66667 86.66667 86.66667 
2 96 90.66667 83.33333 76 73.33333 70.66667 74 74.66667 77.33333 74 74.66667 82 84 76.66667 78 74.66667 76.66667 80.66667 85.33333 
3 103.3333 96.66667 92.66667 79.33333 79.33333 74.66667 80 80 80 76.66667 80.66667 83.33333 88 83.33333 88 84.66667 83.33333 90 90 
4 99.33333 78 77.33333 78.66667 78 78 83.33333 82.66667 83.33333 79.33333 78 76.66667 76.66667 80 82.66667 84 81.33333 81.33333 81.33333 
5 86.66667 81.33333 70.66667 66.66667 80.66667 80 76.66667 78 80 83.33333 84.66667 90 86 90.66667 88.66667 83.33333 89.33333 92.66667 92 
6 93.33333 78 74.66667 66.66667 82 80 76.66667 73.33333 68.66667 78 78.66667 76.66667 78 82 83.33333 76.66667 88.66667 86 85.33333 
7 94 92.66667 66.66667 70.66667 76.66667 73.33333 67.33333 67.33333 68 86.66667 83.33333 86 83.33333 84.66667 94.66667 94.66667 90 90 85.33333 
8 82.66667 85.33333 72 73.33333 70.66667 72.66667 68 71.33333 74.66667 78 76.66667 80 80 88.66667 83.33333 85.33333 85.33333 86.66667 90.66667 
9 82 80.66667 76.66667 66 76 66.66667 68 70 72.66667 80 82.66667 82.66667 86.66667 90.66667 86.66667 88 91.33333 96.66667 88 
10 90.66667 90 78.66667 66.66667 70.66667 66.66667 72 72 78 76.66667 78 81.33333 87.33333 93.33333 89.33333 86.66667 90.66667 94.66667 96.66667 
11 96.66667 88 88 68 80.66667 77.33333 74.66667 81.33333 81.33333 80 85.33333 88 88.66667 83.33333 86.66667 93.33333 90 95.33333 95.33333 
12 98 87.33333 80 97.33333 69.33333 75.33333 78.66667 76 79.33333 76.66667 79.33333 80 86.66667 96.66667 98 95.33333 93.33333 94 96.66667 
13 91.33333 91.33333 91.33333 69.33333 92.66667 100 82.66667 69.33333 74 76.66667 76.66667 78 76 76.66667 83.33333 84 79.33333 92 90 
14 90 91.33333 83.33333 79.33333 76 73.33333 69.33333 77.33333 84 82.66667 80.66667 84.66667 88 88.66667 89.33333 88.66667 88 89.33333 90.66667 
15 86.66667 86.66667 86 86.66667 84.66667 81.33333 78.66667 76.66667 77.33333 78 82 80 79.33333 83.33333 88.66667 86.66667 86.66667 92.66667 89.33333 
16 83.33333 83.33333 84.66667 84.66667 86.66667 80.66667 82 78.66667 70.66667 76 74.66667 84 83.33333 82 79.33333 76.66667 83.33333 78 94 
17 96.66667 96.66667 82 82 76.66667 78 78 80 76.66667 82 82.66667 86.66667 88 88.66667 88 86.66667 86.66667 89.33333 80 
18 100 99.33333 86 86.66667 83.33333 70.66667 99.33333 89.33333 86.66667 88 88 86.66667 89.33333 89.33333 86.66667 84.66667 90 90.66667 90 
19 103.3333 79.33333 81.33333 79.33333 81.33333 74 84 68 76.66667 80 76.66667 78 76.66667 80 82 86.66667 83.33333 93.33333 92 
20 90 86.66667 86.66667 90 86.66667 90 88.66667 90 92 92.66667 90.66667 94 94.66667 93.33333 93.33333 92 92 86.66667 93.33333 
21 96.66667 86.66667 85.33333 80 71.33333 67.33333 67.33333 68 71.33333 71.33333 76.66667 78.66667 80 82 81.33333 82 84.66667 82 86.66667 
22 90 89.33333 91.33333 89.33333 91.33333 90 83.33333 80.66667 76.66667 78 80 77.33333 82 76.66667 85.33333 83.33333 89.33333 89.33333 93.33333 
23 87.33333 83.33333 83.33333 84 83.33333 86 80.66667 84.66667 83.33333 83.33333 83.33333 82.66667 87.33333 91.33333 96 93.33333 92 88 86.66667 
24 78.66667 79.33333 82 74.66667 78.66667 74.66667 78 83.33333 93.33333 94.66667 90.66667 93.33333 86.66667 87.33333 88 93.33333 88 89.33333 99.33333 
25 83.33333 83.33333 81.33333 81.33333 78.66667 81.33333 78 76 83.33333 89.33333 83.33333 86.66667 87.33333 84 83.33333 86 86.66667 85.33333 82.66667 
26 106.6667 105.3333 97.33333 94.66667 90 92 93.33333 93.33333 92.66667 90 92 93.33333 86 80.66667 81.33333 86.66667 86.66667 83.33333 86.66667 
27 110 96.66667 86.66667 88 91.33333 86.66667 80.66667 82 88 76.66667 77.33333 76.66667 78.66667 86.66667 90 90 90 96.66667 83.33333 
28 81.33333 80 84 79.33333 86.66667 86 75.33333 78.66667 74.66667 73.33333 72.66667 78 72 72.66667 76 79.33333 80.66667 80 96.66667 
29 80 82.66667 86 88 87.33333 76.66667 75.33333 70 68 72.66667 72.66667 73.33333 74.66667 78 77.33333 76.66667 73.33333 76.66667 78 
30 83.33333 83.33333 84.66667 84.66667 86.66667 80.66667 82 78.66667 70.66667 76 74.66667 84 83.33333 82 79.33333 76.66667 83.33333 78 80 
 
 VAS RSS 
S.NO 0HR 1HR 2HR 3HR 4HR 5HR 6HR 8HR 10HR 12HR 16HR 20HR 24HR 0HR 1HR 2HR 3HR 4HR 5HR 6HR 8HR 10HR 12HR 16HR 20HR 24HR 
1 8 0 0 0 0 0 0 2 2 1 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
2 8 0 0 0 0 0 1 2 3 1 1 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
3 8 0 0 0 0 0 0 0 2 1 1 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
4 8 0 0 0 0 0 0 1 1 2 1 2 2 1 2 2 2 3 3 3 3 3 3 3 2 2 
5 7 0 0 0 0 0 0 2 3 1 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
6 7 0 0 0 0 0 0 1 2 3 2 2 2 1 2 3 3 2 2 2 2 2 2 2 2 2 
7 8 0 0 0 0 0 0 2 3 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
8 8 0 0 0 0 0 1 3 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
9 7 0 0 0 0 0 0 0 2 1 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
10 8 0 0 0 0 0 0 0 0 2 1 1 2 1 2 2 2 2 2 3 3 3 3 2 2 2 
11 8 0 0 0 0 0 0 2 2 1 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
12 8 0 0 0 0 0 0 0 2 3 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
13 8 0 0 0 0 0 0 2 3 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
14 8 0 0 0 0 0 0 0 0 1 2 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
15 8 0 0 0 0 0 0 0 1 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
16 8 0 0 0 0 0 0 0 2 3 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
17 8 0 0 0 0 0 0 1 1 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
18 8 0 0 0 0 0 0 1 3 1 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
19 8 0 0 0 0 0 0 1 1 3 1 1 1 1 2 2 2 3 3 3 3 2 2 2 2 2 
20 8 0 0 0 0 0 1 1 1 3 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
21 8 0 0 0 0 0 0 1 2 1 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
22 8 0 0 0 0 0 0 1 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
23 7 0 0 0 0 0 0 0 2 1 1 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
24 8 0 0 0 0 0 1 3 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
25 8 0 0 0 0 0 1 3 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
26 7 0 0 0 0 0 0 2 2 1 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
27 8 0 0 0 0 0 0 2 1 1 1 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
28 8 0 0 0 0 0 0 0 1 3 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
29 8 0 0 0 0 0 0 0 1 3 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
30 8 0 0 0 0 0 0 0 1 3 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 
 S.NO ONSET DURATION APGAR SCORE 
 
CCOMPLICATIONS 
SENSORY  MOTOR ANALGESIA 1MIN 5MIN    PONV PRURITUS HYPOTENSION BRADYCARDIA DROWSINESS 
RESPIRATORY 
DEPRESSION 
1 120 225 530 8 9 2 2 2 2 2 2 
2 90 170 620 7 8 2 2 2 2 2 2 
3 120 130 690 8 9 1 2 2 2 2 2 
4 130 275 770 8 9 2 2 2 2 1 2 
5 135 270 600 8 9 2 2 2 2 2 2 
6 105 240 700 8 9 2 2 2 2 1 2 
7 135 185 614 8 9 1 2 2 2 2 2 
8 102 160 455 6 8 2 2 2 2 2 2 
9 92 300 645 7 9 2 2 1 2 2 2 
10 58 70 815 8 9 2 2 2 2 1 2 
11 55 75 665 8 9 1 2 2 2 2 2 
12 105 192 720 7 8 2 2 2 2 2 2 
13 135 180 550 6 8 2 2 2 2 2 2 
14 55 160 800 8 9 2 2 2 2 2 2 
15 105 165 815 8 9 2 2 2 2 2 2 
16 60 108 740 8 9 2 2 2 2 2 2 
17 100 136 700 8 9 2 2 2 2 2 2 
18 65 120 640 8 9 1 2 2 2 2 2 
19 105 162 795 7 9 2 2 2 2 1 2 
20 50 105 730 8 9 2 2 2 2 2 2 
21 75 120 665 8 9 2 2 2 2 2 2 
22 80 100 510 8 9 2 2 2 2 2 2 
23 95 135 670 8 9 1 2 2 2 2 2 
24 105 130 600 8 9 1 2 2 2 2 2 
25 192 300 480 8 9 2 2 2 2 2 2 
26 75 115 585 7 9 2 2 2 2 2 2 
27 75 135 615 8 9 2 2 2 2 2 2 
28 58 128 640 8 9 2 2 2 2 2 2 
29 66 150 700 8 9 2 2 2 2 2 2 
30 60 180 730 8 9 2 2 2 2 2 2 
 SpO2 
S.NO pre 0min 1min 3min 5min 10min 15min 30min 45min 60min 45min 90min 120min 180min 240min 300min 360min 8hr 12hr 24hr 
1 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
2 99 99 100 100 100 100 100 100 99 99 99 98 99 99 99 99 99 99 98 99 
3 99 99 99 99 99 100 100 100 100 100 100 100 100 100 99 98 99 99 99 99 
4 99 99 99 99 99 99 99 99 99 98 97 98 98 98 98 99 99 99 99 99 
5 99 99 99 99 99 99 99 99 99 99 99 97 98 99 98 98 98 98 98 99 
6 99 99 99 100 100 100 100 100 100 100 99 99 99 99 99 99 99 99 99 99 
7 99 99 99 99 99 99 99 99 99 99 99 99 98 98 99 99 99 99 99 99 
8 99 99 98 99 99 99 99 99 98 98 99 99 99 99 99 99 99 99 99 99 
9 99 99 98 98 98 98 98 98 99 98 98 100 100 100 99 99 99 99 99 99 
10 99 99 99 99 98 98 99 99 99 98 99 99 98 98 99 99 99 99 99 99 
11 99 99 99 99 98 98 98 98 97 977 97 98 99 99 99 99 99 98 99 99 
12 99 99 98 98 98 98 98 98 98 98 99 98 98 98 98 98 98 98 98 98 
13 99 99 99 99 99 98 98 97 97 97 97 97 99 99 99 99 99 99 99 99 
14 99 99 99 99 98 98 99 99 99 98 99 99 99 99 99 99 99 99 99 99 
15 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
16 99 99 99 100 100 100 100 100 100 100 99 100 99 100 99 100 99 99 99 99 
17 99 99 99 99 100 100 100 100 100 100 100 100 99 99 99 100 100 100 100 100 
18 99 99 99 100 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
19 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
20 99 99 99 99 100 100 100 100 99 99 98 99 99 99 99 99 99 99 98 98 
21 99 99 99 100 98 98 97 97 97 98 99 99 99 99 99 99 98 99 99 99 
22 99 99 99 100 99 98 98 97 99 99 99 99 99 99 98 98 98 98 98 98 
23 99 99 99 100 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
24 99 99 99 99 99 98 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
25 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 98 98 98 
26 99 99 99 99 99 99 99 99 99 98 98 99 99 99 99 99 99 99 99 99 
27 99 99 99 99 100 99 99 99 99 99 99 99 97 97 97 99 99 98 98 99 
28 99 99 99 99 100 98 99 99 99 97 97 98 98 98 98 99 98 98 99 99 
29 99 99 99 99 98 99 99 99 99 98 99 99 99 99 99 99 99 98 99 99 
30 99 99 99 99 100 100 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
 
CONTROL GROUP-basal 
S.NO     NAME AGE SEX WEIGHT HEIGHT DIAGNOSIS ASA DRUG RSS VAS PULSE RR SBP DBP MAP SPO2 
1 Sumathi 20 FEMALE 66 156 primi/oligohydramnios 1 2 1 8 78 16 120 62 81.33333 99 
2 Rusidha ramzuni 22 FEMALE 66 154 previous lscs 1 2 1 7 86 12 120 76 90.66667 99 
3 Nithya 25 FEMALE 58 152 previous lscs 1 2 1 7 74 14 130 76 94 99 
4 Sathya vani 25 FEMALE 64 156 previous lscs 1 2 1 8 80 12 130 86 100.6667 99 
5 Rafia 21 FEMALE 70 158 Primi/preeclampsia 2 2 1 8 76 16 150 90 110 99 
6 Gayathri 24 FEMALE 64 160 previous lscs 1 2 1 7 76 14 120 80 93.33333 99 
7 Vijayalaxmi 35 FEMALE 68 158 previous lscs 1 2 1 7 84 16 120 70 86.66667 99 
8 Sudarvizhi 27 FEMALE 58 152 previous lscs 1 2 1 8 82 18 134 92 106 99 
9 MOHAVLU Fathima 25 FEMALE 68 154 previous lscs/anaemia 2 2 1 8 72 18 140 90 106.6667 99 
10 Vasanthi 24 FEMALE 64 150 previous lscs 1 2 1 8 90 18 140 90 106.6667 99 
11 Sangeetha 24 FEMALE 76 160 previous lscs 1 2 1 8 84 18 120 80 93.33333 99 
12 Stella 28 FEMALE 68 162 previous lscs/anaemia 2 2 1 8 76 18 130 70 90 99 
13 Meena 20 FEMALE 70 156 primi/mobile head 1 2 1 8 80 14 130 70 90 99 
14 Sabina banu 28 FEMALE 74 154 previous lscs 1 2 1 8 84 14 120 80 93.33333 99 
15 Sangeetha 27 FEMALE 64 152 previous lscs 1 2 1 7 80 14 130 80 96.66667 99 
16 Thara banu 25 FEMALE 66 158 previous lscs 1 2 1 7 88 18 130 94 106 99 
17 Punitha 24 FEMALE 68 160 G2/Polyhydramnios 1 2 1 8 86 18 140 80 100 99 
18 Saranya 20 FEMALE 74 160 previous lscs 1 2 1 7 80 16 130 80 96.66667 99 
19 Anjali 19 FEMALE 68 156 primi/mobile head 1 2 1 8 72 12 120 82 94.66667 99 
20 Geetha devi 23 FEMALE 58 152 primi/PIH 2 2 1 8 80 16 120 66 84 99 
21 Karthigai vani 20 FEMALE 58 152   2 2 1 8 72 16 120 60 80 99 
22 Valliammal 30 FEMALE 62 156 previous lscs 1 2 1 8 84 14 130 68 88.66667 99 
23 Sithi sabinabanu 24 FEMALE 64 160 primi/PIH 2 2 1 8 72 16 120 80 93.33333 99 
24 Mythili 30 FEMALE 64 156 previous lscs 1 2 1 8 84 12 130 90 103.3333 99 
25 Saraswathy 27 FEMALE 70 150 primi/bigbaby 2 2 1 8 72 14 120 82 94.66667 99 
26 Ramalaxmi 25 FEMALE 64 162 previous lscs 1 2 1 8 70 16 130 70 90 99 
27 Chithra 25 FEMALE 60 154 primi/PIH 2 2 1 8 78 16 140 90 106.6667 99 
28 Suseela 24 FEMALE 68 155 previous lscs 1 2 1 8 74 16 130 80 96.66667 99 
29 Nandhini 28 FEMALE 65 155 G2/mobile head 1 2 1 8 84 14 140 90 106.6667 99 
30 Devi 23 FEMALE 70 158 previous lscs 1 2 1 8 70 16 120 80 93.33333 99 
 PULSE 
S.NO PRE 0MIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 78 76 88 90 86 88 84 84 80 84 80 86 84 88 84 80 80 82 82 
2 86 82 82 86 80 88 88 96 92 86 88 86 84 86 86 80 80 76 76 
3 74 74 76 74 76 74 78 92 92 90 88 90 90 88 84 86 84 82 82 
4 80 84 80 80 80 82 76 80 84 84 80 86 80 90 80 84 88 84 84 
5 76 78 78 80 90 96 90 92 90 86 82 96 84 80 72 74 70 76 76 
6 76 78 78 76 72 90 92 96 94 90 84 84 82 86 80 80 76 70 70 
7 84 86 88 90 90 88 90 90 84 84 80 84 82 84 78 76 78 74 74 
8 82 84 80 80 86 86 88 86 86 86 86 80 80 80 70 70 72 70 72 
9 72 78 74 78 78 90 92 86 88 88 96 84 88 82 84 89 84 84 84 
10 90 88 98 98 98 94 90 90 90 80 86 80 86 80 76 70 70 72 70 
11 84 82 80 86 86 86 86 84 86 80 78 80 80 80 70 72 70 70 70 
12 76 76 84 84 86 84 86 84 82 80 88 86 88 94 86 84 80 80 84 
13 80 84 84 88 80 88 92 90 92 98 76 72 80 80 84 80 80 74 74 
14 84 88 88 90 90 90 92 96 80 84 70 78 82 76 68 70 64 76 76 
15 80 82 84 88 90 90 90 82 82 78 82 80 82 80 70 70 72 72 70 
16 88 88 80 86 86 86 88 84 86 86 86 88 88 78 74 78 76 76 76 
17 86 88 94 94 90 90 98 96 92 86 88 86 88 80 72 70 70 70 70 
18 80 84 88 88 88 90 92 86 84 80 80 86 84 80 72 72 70 70 70 
19 72 74 74 78 78 98 90 94 94 86 86 86 86 76 80 72 70 70 70 
20 80 86 86 94 94 94 98 98 90 90 90 92 90 84 74 72 70 74 74 
21 72 74 78 86 86 88 90 88 80 80 84 70 80 70 70 70 72 72 72 
22 84 88 86 884 84 82 88 86 74 80 80 88 80 80 74 86 86 80 80 
23 72 76 76 78 90 92 90 86 92 86 80 86 70 70 68 76 76 74 74 
24 84 88 98 96 96 96 90 86 82 84 84 86 76 78 74 72 70 74 74 
25 72 74 74 74 74 78 90 90 94 94 84 86 84 84 80 76 72 72 72 
26 70 76 88 88 88 90 90 86 86 86 82 80 80 86 86 80 80 82 82 
27 78 80 80 88 88 86 80 80 70 72 70 78 80 76 70 70 72 78 78 
28 74 78 88 96 102 106 98 94 90 90 84 80 84 80 70 70 70 72 72 
29 84 88 90 90 88 86 88 90 90 88 82 82 86 80 76 70 80 80 80 
30 70 74 72 80 86 86 86 88 82 88 84 88 80 82 80 80 70 70 70 
RR  
S.NO PREOP OMIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 16 16 18 18 18 20 18 16 18 18 18 18 20 18 18 16 18 18 18 
2 12 14 14 16 14 14 14 12 14 14 16 18 18 18 18 16 18 18 18 
3 14 14 14 14 16 16 14 14 16 14 12 14 14 14 14 18 18 20 20 
4 12 12 12 12 12 12 14 14 14 12 14 14 16 14 14 12 12 12 12 
5 16 16 14 14 16 16 14 14 14 12 12 18 18 18 16 14 16 16 16 
6 14 14 14 16 14 14 12 16 16 14 16 18 18 16 16 14 14 16 14 
7 16 18 16 16 18 16 16 16 16 16 16 16 16 14 16 16 16 18 18 
8 18 18 16 18 18 16 16 18 18 16 18 18 18 16 16 16 16 16 14 
9 18 16 18 18 16 16 16 16 18 16 16 16 16 14 14 14 14 16 16 
10 18 18 18 20 20 20 20 16 18 20 18 18 18 14 16 14 14 14 16 
11 18 20 20 20 20 20 18 20 20 20 18 18 16 14 14 14 19 20 20 
12 18 18 18 18 16 18 18 18 18 16 18 18 18 16 16 16 14 14 18 
13 14 14 14 14 14 14 14 16 16 14 12 12 14 16 16 12 14 14 14 
14 14 14 12 12 14 14 16 16 16 16 16 16 16 14 12 16 14 14 14 
15 14 14 14 12 12 12 14 14 16 16 16 14 14 14 14 16 16 16 16 
16 18 18 18 18 16 16 16 18 20 20 20 16 16 14 16 14 16 16 16 
17 18 18 18 18 18 18 16 16 18 16 16 18 16 16 14 16 16 14 16 
18 16 16 14 16 16 14 14 14 16 16 16 16 16 18 14 16 16 14 16 
19 12 14 14 14 14 14 12 14 14 14 16 16 16 14 16 16 14 14 14 
20 16 16 18 16 16 16 14 14 14 16 16 16 16 16 14 16 16 14 14 
21 16 16 16 16 18 16 14 14 14 16 14 12 14 14 14 14 14 14 14 
22 14 14 14 16 16 16 18 18 18 16 16 16 16 16 14 14 14 14 14 
23 16 16 16 18 18 18 16 18 16 18 18 18 18 14 14 14 14 14 14 
24 12 14 14 14 16 16 16 14 16 14 16 16 16 16 16 16 16 16 16 
25 14 14 14 14 12 14 16 14 16 16 16 14 18 16 16 14 12 16 16 
26 16 18 18 18 18 18 18 18 16 14 16 16 18 14 16 14 14 14 14 
27 16 16 18 18 16 16 18 16 16 14 14 16 14 16 16 14 14 16 14 
28 16 16 16 16 18 18 18 18 18 18 18 18 18 16 14 14 14 16 16 
29 14 14 14 14 16 14 16 16 16 14 14 16 14 14 14 12 14 14 14 







N 1MIN 3MIN 5MIN 10MIN 15MIN 
30MI






N 8HR 12HR 24HR 
1 
120 120 110 110 108 100 108 108 110 110 110 118 120 124 120 128 126 130 130 
2 120 120 120 100 100 102 100 110 102 110 122 120 126 130 122 120 120 120 122 
3 
130 120 120 118 118 114 118 110 110 112 110 110 122 120 134 132 130 130 130 
4 130 118 118 120 120 120 118 120 110 120 122 124 130 132 126 120 128 130 130 
5 
150 130 130 126 130 112 110 108 118 110 120 124 120 128 120 120 124 122 124 
6 120 120 120 120 120 100 100 110 112 110 110 110 120 130 124 120 122 120 120 
7 
120 120 102 102 100 110 90 100 106 102 110 112 120 126 124 124 130 132 132 
8 134 136 130 120 110 110 100 120 110 110 110 118 120 116 116 110 110 118 116 
9 
140 140 130 126 110 110 110 108 110 110 110 120 124 120 122 126 128 130 130 
10 140 130 120 122 120 120 108 108 112 110 110 110 120 110 110 110 110 110 110 
11 
120 112 110 104 102 104 104 110 118 110 108 110 110 112 120 110 112 120 120 
12 130 124 110 110 104 104 104 108 108 110 112 118 122 120 120 112 110 124 130 
13 
130 130 120 120 112 112 110 102 104 110 120 112 110 120 120 130 130 120 120 
14 120 120 112 102 102 100 96 106 110 112 120 110 102 124 110 112 110 120 120 
15 
130 110 112 110 110 104 100 104 104 110 120 118 116 114 118 120 110 110 110 
16 130 130 126 126 120 120 120 120 110 120 124 122 120 110 112 120 120 120 120 
17 
140 130 110 110 110 108 108 110 110 120 120 120 130 120 124 122 130 130 130 
18 130 130 110 100 102 100 90 106 110 106 108 110 120 110 110 118 120 120 118 
19 
120 120 112 110 110 110 100 96 108 116 120 120 128 122 120 122 120 120 120 
20 120 120 110 110 110 110 104 110 116 120 116 122 124 126 124 118 110 110 110 
21 
120 120 124 110 108 108 106 102 110 116 122 120 110 120 124 124 124 120 120 
22 130 120 110 110 110 110 112 112 118 120 120 124 120 120 120 120 120 120 120 
23 
120 120 104 103 103 110 110 110 108 110 100 110 110 124 120 110 120 120 120 
24 130 108 108 110 110 108 100 108 110 110 120 120 120 110 110 120 120 120 120 
25 
120 120 112 112 112 110 112 108 110 106 110 112 112 110 108 110 110 110 110 
26 130 120 122 110 110 112 110 110 118 122 118 110 130 126 120 120 120 120 120 
27 
140 138 110 110 102 100 104 102 112 110 120 124 120 124 122 128 126 120 128 
28 130 124 110 110 90 108 104 104 110 110 120 120 110 110 120 120 120 110 110 
29 
140 136 120 120 120 108 104 102 104 110 110 124 120 120 120 120 120 120 120 









N 5MIN 10MIN 
15MI















1 62 64 60 62 62 50 52 56 60 62 60 70 74 72 80 86 82 80 80 
2 76 70 72 56 52 52 50 60 60 60 76 70 84 70 74 70 70 74 74 
3 76 68 76 68 60 62 60 64 70 70 70 70 74 76 86 82 74 68 70 
4 86 76 76 70 70 66 70 60 60 70 80 78 74 84 78 72 78 70 70 
5 90 70 72 70 72 68 64 62 70 68 70 80 80 86 80 74 84 78 78 
6 80 80 70 80 70 60 60 60 66 68 62 60 70 64 80 76 72 74 74 
7 70 70 60 60 56 54 52 54 58 52 62 60 70 74 72 70 70 74 74 
8 92 96 80 76 70 70 70 64 56 70 70 74 78 70 74 72 70 72 72 
9 90 90 90 90 80 70 56 62 60 68 62 70 78 70 74 76 76 70 70 
10 90 90 70 70 70 70 60 60 56 50 56 56 68 74 68 70 70 74 74 
11 120 80 70 70 60 56 54 50 58 70 70 66 70 74 76 74 72 70 70 
12 130 70 70 74 56 56 50 50 58 60 60 70 74 74 62 60 62 70 80 
13 70 72 68 60 58 50 54 54 54 62 60 70 70 70 70 80 70 70 70 
14 80 76 70 56 58 52 52 50 52 60 62 62 66 74 70 74 60 70 70 
15 80 70 72 70 70 76 68 50 76 70 70 70 72 70 70 70 64 64 64 
16 94 92 74 74 70 70 70 74 74 70 72 84 78 74 72 70 60 60 60 
17 80 70 72 70 72 60 62 62 64 70 72 80 90 80 70 68 80 70 70 
18 88 82 70 70 70 74 74 60 64 64 56 64 66 72 74 70 74 76 76 
19 82 80 66 60 66 66 60 50 64 68 72 70 68 72 70 72 74 72 72 
20 60 60 54 56 56 50 52 62 64 70 72 74 64 70 72 74 60 66 66 
21 60 62 64 60 64 60 54 54 62 62 76 74 76 70 70 70 80 80 80 
22 68 60 66 66 50 52 54 54 56 66 76 76 76 72 70 80 80 80 80 
23 80 70 66 60 66 70 62 62 62 60 68 72 72 70 70 80 70 70 70 
24 90 78 70 70 70 72 50 56 62 60 70 80 70 70 74 70 70 70 70 
25 82 82 80 80 66 64 66 56 62 64 68 70 70 62 64 60 60 70 70 
26 70 70 70 70 64 48 50 62 64 70 76 70 74 74 70 80 80 80 80 
27 90 80 80 70 70 50 50 52 54 64 60 70 80 86 74 72 78 70 70 
28 80 80 60 60 52 58 60 60 60 62 70 70 60 60 80 80 70 60 60 
29 90 90 60 60 60 56 52 54 62 64 68 74 78 80 80 60 60 70 70 
30 80 82 64 60 66 60 60 64 64 76 60 64 70 74 76 70 80 80 60 
 MAP 
S.NO PREOP 0MIN 1MIN 3MIN 5MIN 10MIN 15MIN 30MIN 45MIN 60MIN 90MIN 120MIN 180MIN 240MIN 300MIN 360MIN 8HR 12HR 24HR 
1 81.33333 82.66667 76.66667 78 77.33333 66.66667 70.66667 73.33333 76.66667 78 76.66667 86 89.33333 89.33333 93.33333 100 96.66667 96.66667 96.66667 
2 90.66667 86.66667 88 70.66667 68 68.66667 66.66667 76.66667 74 76.66667 91.33333 86.66667 98 90 90 86.66667 86.66667 89.33333 96.66667 
3 94 85.33333 90.66667 84.66667 79.33333 79.33333 79.33333 79.33333 83.33333 84 83.33333 83.33333 90 90.66667 102 98.66667 92.66667 88.66667 90 
4 100.6667 90 90 86.66667 86.66667 84 86 80 76.66667 86.66667 94 93.33333 92.66667 100 94 88 94.66667 90 90 
5 110 90 91.33333 88.66667 91.33333 82.66667 79.33333 77.33333 86 82 86.66667 94.66667 93.33333 100 93.33333 89.33333 97.33333 92.66667 90 
6 93.33333 93.33333 86.66667 93.33333 86.66667 73.33333 73.33333 76.66667 81.33333 82 78 76.66667 86.66667 86 94.66667 90.66667 88.66667 89.33333 93.33333 
7 86.66667 86.66667 74 74 70.66667 72.66667 64.66667 69.33333 74 68.66667 78 77.33333 86.66667 91.33333 89.33333 88 90 93.33333 89.33333 
8 106 109.3333 96.66667 90.66667 83.33333 83.33333 80 82.66667 74 83.33333 83.33333 88.66667 92 85.33333 88 84.66667 83.33333 87.33333 93.33333 
9 106.6667 106.6667 103.3333 102 90 83.33333 74 77.33333 76.66667 82 78 86.66667 93.33333 86.66667 90 92.66667 93.33333 90 86.66667 
10 106.6667 103.3333 86.66667 87.33333 86.66667 86.66667 76 76 74.66667 70 74 74 85.33333 86 82 83.33333 83.33333 86 90 
11 120 90.66667 83.33333 81.33333 74 72 70.66667 70 78 83.33333 82.66667 80.66667 83.33333 86.66667 90.66667 86 85.33333 86.66667 86 
12 74 88 83.33333 86 72 72 68 69.33333 74.66667 76.66667 77.33333 86 90 89.33333 81.33333 77.33333 78 88 86.66667 
13 90 91.33333 85.33333 80 76 70.66667 72.66667 70 70.66667 78 80 84 83.33333 86.66667 86.66667 96.66667 90 86.66667 96.66667 
14 93.33333 90.66667 84 71.33333 72.66667 68 66.66667 68.66667 71.33333 77.33333 81.33333 78 78 90.66667 83.33333 86.66667 76.66667 86.66667 86.66667 
15 96.66667 83.33333 85.33333 83.33333 83.33333 85.33333 78.66667 68 85.33333 83.33333 86.66667 86 86.66667 84.66667 86 86.66667 79.33333 79.33333 86.66667 
16 106 104.6667 91.33333 91.33333 86.66667 86.66667 86.66667 89.33333 86 86.66667 89.33333 96.66667 92 86 85.33333 86.66667 80 80 79.33333 
17 100 90 84.66667 83.33333 84.66667 76 77.33333 78 79.33333 86.66667 88 93.33333 103.3333 93.33333 88 86 96.66667 90 80 
18 102 98 83.33333 80 80.66667 82.66667 79.33333 75.33333 79.33333 78 73.33333 79.33333 84 84.66667 86 86 89.33333 90.66667 90 
19 94.66667 93.33333 81.33333 76.66667 80.66667 80.66667 73.33333 65.33333 78.66667 84 88 86.66667 88 88.66667 86.66667 88.66667 89.33333 88 90 
20 80 80 72.66667 74 74 70 69.33333 78 81.33333 86.66667 86.66667 90 84 88.66667 89.33333 88.66667 76.66667 80.66667 88 
21 80 81.33333 84 76.66667 78.66667 76 71.33333 70 78 80 91.33333 89.33333 87.33333 86.66667 88 88 94.66667 93.33333 80.66667 
22 88.66667 80 80.66667 80.66667 70 71.33333 73.33333 73.33333 76.66667 84 90.66667 92 90.66667 88 86.66667 93.33333 93.33333 93.33333 93.33333 
23 93.33333 86.66667 78.66667 74.33333 78.33333 83.33333 78 78 77.33333 76.66667 78.66667 84.66667 84.66667 88 86.66667 90 86.66667 86.66667 93.33333 
24 103.3333 88 82.66667 83.33333 83.33333 84 66.66667 73.33333 78 76.66667 86.66667 93.33333 86.66667 83.33333 86 86.66667 86.66667 86.66667 86.66667 
25 94.66667 94.66667 90.66667 90.66667 81.33333 79.33333 81.33333 73.33333 78 78 82 84 84 78 78.66667 76.66667 76.66667 83.33333 86.66667 
26 90 86.66667 87.33333 83.33333 79.33333 69.33333 70 78 82 87.33333 90 83.33333 92.66667 91.33333 86.66667 93.33333 93.33333 93.33333 76.66667 
27 106.6667 99.33333 90 83.33333 80.66667 66.66667 68 68.66667 73.33333 79.33333 80 88 93.33333 98.66667 90 90.66667 94 86.66667 93.33333 
28 96.66667 94.66667 76.66667 76.66667 64.66667 74.66667 74.66667 74.66667 76.66667 78 86.66667 86.66667 76.66667 76.66667 93.33333 93.33333 86.66667 76.66667 89.33333 
29 106.6667 105.3333 80 80 80 73.33333 69.33333 70 76 79.33333 82 90.66667 92 93.33333 93.33333 80 80 86.66667 76.66667 
30 93.33333 94.66667 79.33333 76.66667 81.33333 73.33333 74 79.33333 409.3333 88 80 82 86.66667 86 88 86.66667 93.33333 93.33333 86.66667 
 
  
                                                             VAS                                                                         RSS 
S.NO 
0HR 1HR 2HR 3HR 4HR 5HR 6HR 8HR 10HR 12HR 16HR 20HR 24HR 0HR 1HR 2HR 3HR 4HR 5HR 6HR 8HR 10HR 12HR 16HR 20HR 24HR 
1 8 0 2 3 2 6 3 2 2 6 4 3 4 1 2 2 2 1 2 2 2 2 2 2 2 2 
2 8 0 0 3 2 4 2 4 6 2 3 3 3 1 2 2 2 1 2 2 2 1 2 2 1 2 
3 8 0 0 2 4 2 2 4 3 3 6 2 3 1 2 2 2 1 2 2 1 2 2 1 2 2 
4 8 0 2 4 2 2 7 3 2 2 3 2 2 1 2 2 2 1 1 2 2 2 2 1 2 2 
5 8 0 0 2 3 2 4 4 6 3 3 4 3 1 2 2 2 2 1 2 2 2 1 2 2 2 
6 7 0 0 1 2 4 2 2 4 4 6 3 2 1 2 2 2 2 1 2 2 2 1 2 2 2 
7 7 0 0 3 2 2 4 2 2 3 3 2 2 1 2 2 1 1 2 1 1 2 2 1 1 2 
8 8 0 2 3 2 4 4 3 2 2 4 3 3 1 2 2 2 1 1 2 2 2 2 2 1 2 
9 8 0 0 2 2 4 3 4 4 3 3 4 4 1 2 2 2 2 2 2 2 2 1 2 2 2 
10 8 0 0 3 2 2 4 4 3 3 3 4 4 1 2 2 2 2 1 2 1 1 2 2 2 2 
11 8 0 0 3 2 2 3 3 4 4 3 4 3 1 2 2 2 2 1 2 2 2 1 1 2 2 
12 8 0 0 3 3 3 5 5 3 5 4 4 4 1 2 2 2 2 1 2 2 1 2 2 2 2 
13 8 0 0 2 4 2 3 3 4 2 4 4 4 1 2 2 2 2 1 2 1 2 2 1 2 2 
14 8 0 1 3 3 3 5 5 3 3 5 4 4 1 2 2 1 2 2 2 1 2 2 2 1 2 
15 7 0 2 3 3 3 4 4 4 4 4 4 4 1 2 2 1 1 2 2 2 2 1 2 2 2 
16 7 0 0 1 3 3 3 4 4 4 5 5 5 1 2 2 2 1 2 2 2 2 1 2 2 2 
17 8 0 0 3 3 3 3 4 4 4 4 4 4 1 2 2 2 1 2 2 1 1 2 2 2 2 
18 7 0 0 3 3 4 4 5 4 4 4 6 6 1 2 2 2 1 2 2 2 1 2 2 2 2 
19 8 0 0 2 3 3 4 4 4 4 4 4 4 1 2 2 2 2 1 2 2 1 2 2 2 2 
20 8 0 0 2 3 3 4 4 5 5 5 5 5 1 2 2 2 1 2 2 2 1 2 2 2 2 
21 8 0 0 3 3 4 3 4 4 5 5 4 4 1 2 2 2 2 1 1 2 2 2 1 2 2 
22 7 0 0 1 3 3 3 3 5 5 6 5 5 1 2 2 2 2 2 1 2 2 1 2 2 2 
23 7 0 1 3 3 4 4 4 4 5 5 5 5 1 2 2 2 2 2 2 1 2 2 2 2 2 
24 8 0 0 1 3 4 4 4 5 5 5 5 5 1 2 2 2 2 1 2 2 1 2 2 2 2 
25 8 0 0 2 3 3 4 4 4 4 4 4 4 1 2 2 2 2 2 2 1 2 2 1 2 2 
26 8 0 0 2 3 3 3 4 4 4 5 5 5 1 2 2 2 2 2 1 2 2 2 1 2 2 
27 8 0 1 3 3 3 3 4 4 4 4 4 4 1 2 2 2 1 1 2 2 2 2 2 2 2 
28 8 0 0 2 4 4 4 4 5 5 6 6 6 1 2 2 2 2 1 2 2 2 2 1 2 2 
29 8 0 0 1 3 3 3 3 5 5 5 6 6 1 2 2 2 2 2 2 1 2 1 2 2 2 
30 8 0 1 3 3 3 4 4 4 4 6 6 6 1 2 2 1 2 2 1 1 2 2 2 2 2 
 
               
ONSET   DURATION 
APGAR 
SCORE   
                                               
CCOMPLICATIONS   COMPLICATIONS       
S.NO 
SENSORY  MOTOR ANALGESIA 1 MIN 
5 
MIN    PONV PRURITUS HYPOTENSION BRADYCARDIA DROWSINESS 
RESPIRATORY 
DEPRESSION 
1 195 240 180 7 9 2 2 2 2 2 2 
2 210 240 187 7 9 1 2 2 2 2 2 
3 150 240 205 7 8 2 2 2 2 2 2 
4 135 240 165 8 9 2 2 1 2 2 2 
5 180 210 210 8 9 2 2 2 2 2 2 
6 200 226 275 8 9 2 2 2 2 2 2 
7 252 300 165 8 9 2 2 2 2 2 2 
8 252 300 190 7 9 2 2 2 2 2 2 
9 200 240 190 7 9 1 2 2 2 2 2 
10 175 220 195 7 9 2 2 2 2 2 2 
11 185 240 195 7 8 2 2 2 2 2 2 
12 190 300 180 7 8 2 2 2 2 2 2 
13 165 215 195 8 9 1 2 2 2 2 2 
14 312 360 190 8 9 2 2 2 2 2 2 
15 225 260 165 7 9 1 2 1 2 2 2 
16 240 300 215 7 9 2 2 2 2 2 2 
17 205 240 174 8 9 2 2 2 2 2 2 
18 200 255 152 8 9 2 2 2 2 2 2 
19 270 300 190 8 9 2 2 2 2 2 2 
20 225 264 190 8 9 2 2 2 2 2 2 
21 260 300 173 6 8 2 2 2 2 2 2 
22 210 270 200 7 9 2 2 2 2 2 2 
23 240 270 180 7 9 1 2 2 2 2 2 
24 230 275 210 8 9 2 2 2 2 2 2 
25 230 255 225 6 8 2 2 2 2 2 2 
26 180 310 200 7 9 2 2 2 2 2 2 
27 150 180 180 7 9 2 2 1 2 2 2 
28 190 280 180 7 9 2 2 2 2 2 2 
29 165 210 195 8 9 2 2 2 2 2 2 





basal 0min 1min 3min 5min 10min 15min 30min 45min 60min 90min 120min 180min 240min 300min 360min 8hr 12hr 24hr 
1 99 99 99 99 98 99 98 99 99 99 99 98 98 98 98 99 99 99 98 
2 99 99 99 98 99 100 100 99 99 99 100 100 99 99 99 99 99 99 99 
3 99 99 99 99 99 99 98 98 98 98 98 97 98 97 98 97 98 99 99 
4 99 99 99 99 98 99 99 99 99 97 99 99 99 99 99 99 99 99 99 
5 98 99 99 99 99 99 99 99 99 99 99 98 98 98 98 98 98 98 98 
6 98 99 99 99 99 99 99 100 100 100 99 98 98 98 99 99 99 99 99 
7 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 100 100 100 100 
8 99 99 100 100 100 100 100 100 100 100 100 99 99 99 99 99 99 99 99 
9 99 99 100 99 100 99 99 99 99 99 99 99 99 99 99 98 99 99 99 
10 98 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 98 99 99 
11 98 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 98 98 
12 99 99 99 99 99 99 99 99 99 99 98 98 99 98 98 98 98 98 99 
13 99 99 99 99 98 99 99 99 97 97 97 99 99 99 99 98 98 98 98 
14 99 99 99 99 99 99 99 98 98 99 98 98 98 98 99 99 99 99 99 
15 99 99 99 99 100 100 99 99 100 100 100 100 99 99 98 98 98 99 99 
16 99 99 99 99 100 100 100 100 100 100 100 99 99 99 99 99 99 99 99 
17 99 99 100 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
18 99 99 100 99 99 98 98 98 98 98 99 99 99 99 99 99 99 99 99 
19 99 99 100 99 99 99 98 98 98 98 98 98 98 98 97 97 98 99 99 
20 99 99 100 99 99 99 99 100 100 100 100 99 100 98 98 99 99 100 100 
21 100 99 98 99 99 99 99 99 99 99 98 99 98 99 99 98 97 97 98 
22 100 98 98 99 99 98 98 99 99 99 98 99 98 98 98 98 98 98 98 
23 99 98 97 98 99 99 99 98 98 98 99 99 99 98 98 99 99 98 98 
24 99 98 99 99 99 99 99 99 100 99 99 99 99 99 99 99 99 99 99 
25 99 98 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 98 
26 100 99 99 99 99 99 99 98 99 99 99 98 99 99 99 99 99 99 99 
27 99 99 99 99 99 99 99 99 99 99 99 98 98 98 97 97 98 98 99 
28 99 99 99 99 99 99 99 99 99 99 98 99 100 99 99 99 99 99 99 
29 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
30 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
 
